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ABSTRACT OF DISSERTATION

THE DRUGS/VIOLENCE NEXUS: THEORY TESTING AND BEHAVIORAL
HEALTH FACTORS AMONG JUSTICE-INVOLVED APPALACHIAN WOMEN

This study examined the relationship between drug use and violence among justiceinvolved women in Appalachian Kentucky. Goldstein’s (1985) conceptual framework
was used as a theoretical guide in formulating the drugs and violence relationships.
Therefore, three types of drug use and violence relationships were explored, including: 1)
psychopharmacological violence; economic-compulsive violence; and 3) systemic
violence. Although these drug-related violence typologies have been investigated, little
research has been devoted to rural justice-involved women. Moreover, to date no studies
have examined how these drug/violence relationships might be associated with
behavioral health factors. Ergo, there were three aims of the current study. First, to build
psychopharmacological, economic-compulsive, and systemic drug/violence predictive
group models. Second, examine the associations between mental health symptomology
and predicted group models. Third, examine the associations between infectious disease
risk-factors and predicted group models. This study used secondary data from a NIDAfunded grant focused on risk reduction among high-risk incarcerated women in
Appalachia (N=400). All study recruitment and data collection procedures were approved
by the university IRB. Predicted drugs/violence groups were developed using a series of
discriminant function analyses. Predicted group models were examined for associations
with mental health symptomology and risk factors for infectious disease using a series of
binary logistic regression analyses. Results indicated that rural justice-involved women
can be discriminated into distinct drugs/violence subgroups, and the
psychopharmacological group showed the greatest prevalence. In addition, several
behavioral health factors were uniquely associated with the psychopharmacological
group and the economic-compulsive group. These findings could offer novel
considerations for theory development regarding the drug-related risks for violence
victimization among rural justice-involved women. The current research may also inform
future traditional substance use treatment (e.g., outpatient or residential) and jail-based
treatment (e.g., brief intervention) for rural women. Implications for theory development,
substance use treatment and policy, future research, and the social work profession were
discussed.
Keywords: Drugs, Violence, Theory, Appalachia, Incarceration, Women’s Health
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Chapter I: Introduction
This section provides an outline of the purpose of the current study and an
overview of pertinent research. A profile of the Appalachian region is provided;
including, an overview of the predominant cultural characteristics and economic
conditions, as well as the health disparities and social determinants of health within the
region. A comprehensive review of substance use in Appalachia is also provided;
including, epidemiology of substance use, differentiated patterns of substance use
between men and women, differential patterns of substance use between urban and rural
populations, and a brief description of Kentucky’s state drug policy efforts aimed at
mitigating the adverse effects of the opioid crisis. The background information on
substance use will segue to an integrated summary of violence victimization, and how it
and substance use are an interrelated public health concern for women. To this end,
Goldstein’s (1985) tripartite conceptual framework is introduced with support from
relevant literature and is used to conceptually guide the summary of the drugs-violence
victimization nexus among women.
Statement of the Problem
The United States (U.S.) is witnessing its most fatal drug-related crisis in its
history as demonstrated by the fact that drug-related deaths are now the leading cause of
unintentional death (Beletsky & Davis, 2017). Since the mid-2000s drug-related deaths in
the US have increased precipitously, as recent reporting estimated that 72,000 died of a
drug overdose in 2017 (Center for Disease Control and Prevention, 2018). An estimated
10.6% of Americans (28.6 million) ages 12 years or older used any controlled substances
in the past month (SAMHSA, 2017). That equates to about 1 in 10 individuals aged 12 or
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older in the U.S. used illicit substances in the past month. The most commonly used illicit
substance in the past month was marijuana (24 million). About 6.2 million people
reported using psychotherapeutic drugs, and among them, 3.3 million people were
misusers of prescription pain medication. In other words, among specific illicit drugs,
prescription pain medication was the second highest used substance behind marijuana
(SAMHSA, 2017). Past 12 months prevalence rates (in millions) for the remaining illicit
substances is as follows: misuse of prescription tranquilizers (2.0); cocaine (1.9); misuse
of prescription stimulants (1.7); hallucinogens (1.4); methamphetamine (0.7); inhalants
(0.6); misuse of prescription sedatives (0.5); and heroin (0.5).
To better understand the current drug-related public health crisis, it is important to
contextualize how opioid prescription practices have changed over the recent decades. At
the national level, the assessment and treatment of chronic non-cancer pain underwent
major changes with the issuance of new practice standards of care. For example, in 1998,
the Veterans Health Administration (VHA) implemented an initiative called “Pain as the
5th Vital Sign,” which was strategically designed to improve the quality of patients’ pain
treatment (Tompkins, Hobelmann, & Compton, 2017).
This initiative expanded primary care physician’s opioid prescribing capacity.
Prior to these changes, prescription opioids were typically only considered for the
treatment of severe pain (Hwang, Chang, & Alexander, 2015;Van Zee, 2009).
Concurrently, pharmaceutical manufacturers promoted off-label application of opioids to
ailments that were not traditionally thought of as being treated by this class of medication
(Chou et al., 2015). Taken together, the increasing rate of prescribing opioid analgesics
may have resulted in the high prevalence of prescription opioid misuse and mortality. To
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reign in liberal prescribing practices, most states enacted medical surveillance laws that
aimed to monitor prescribing patters to reduce the illicit use of prescription opioids.
Although well intended, these policy actions have led researchers to suggest that
individuals have been forced to more dangerous opioid analogs (e.g., heroin and
fentanyl), resulting in increases in opioid-related mortality (Beletsky & Davis, 2017;
CDC, 2018).
The Office of National Drug Control Policy’s (ONDCP) recently expanded its
strategy for reducing opioid misuse (Brady, McCauley, & Back, 2015). The ONDCP
initiatives have largely targeted education to patients and providers (e.g., informing the
dangers of misuse), and policy reform (e.g., Prescription Drug Monitoring Programs).
Apart from federal policies, state and local governments have also enacted policies to
reduce opioid misuse, with varied objectives and approaches (Dasgupta et al., 2014;
Cicero et al., 2014). For instance, policy measures have attempted to address this problem
in many ways by reducing supply, by monitoring use and potential misuse, by reversing
overdoses, by increasing access to treatment and prevention, and by humanizing the
epidemic (Koh, 2015).
At the forefront of enforcement efforts are Prescription Drug Monitoring
Programs (PMDPs), which electronically tracked prescriptions of all controlled drugs.
Prescription Drug Monitoring Programs currently operate in 49 states except Missouri
and Washington, DC (Koh, 2015). Although nearly all states have PDMPs, most do not
have legislation that mandates utilization; thus, many states have utilization rates at or
below 50%. As of July 2013, 16 states (Colorado, Delaware, Kentucky, Louisiana,
Massachusetts, Minnesota, Nevada, New Mexico, New York, North Carolina, Ohio,
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Oklahoma, Rhode Island, Tennessee, Vermont, and West Virginia) had legislation
mandating prescribers, and in some cases, dispensers use their respective PDMP
(Haffajee, Jena, & Weiner, 2015). Yet, the mentioned legislative mandates differ in the
conditions under which they must be operated. For example, the Oklahoma statute (2010)
requires checking PDMP only when prescribing methadone (Prescription Monitoring
Programs Center of Excellence, 2014). On the contrary, Kentucky’s PDMP mandates
have wider conditions of application, including all scheduled drugs—perhaps because
Kentucky ranks among the highest prescribers of opioid medication (Keyes, Cerdá,
Brady, Havens, & Galea, 2014).
In general, women represent a population-group that displays an increasing
prevalence rates of substance misuse (SAMHSA, 2017). Compared to men, women more
often present with more significant comorbid conditions, such as mood and anxiety
disorders (Moon, 2017). According to SAMHSA (2017), gender has been found to
predict differences in how men and women administered and were impacted by substance
use. For instance, women have been found to use substances differently (e.g., increased
injection drug use among young women). In addition, women have been found to have
different acute and chronic effects of substance use (e.g., endocrinology, dosage, etc.), to
be more likely to overdose or die from substance use, and to be more likely to use
substances if they are victims of domestic violence (Evans et al., 2015; SAMHSA, 2017).
Gender differences also have been found when investigating the typology of
violent acts (e.g., perpetrator of violence and/or victim of violence) in association to
substance misuse. Past research supports the notion that women are significantly more
likely to be victimized by violent acts than men (Goldstein, 1998; Goldstein, 1985).
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Empirical evidence has also demonstrated that violent perpetrators and victims of
violence have similar characteristics, insofar that they are both vulnerable to violent
behavior (Goldstein, 1985). For instance, an individual using substances may be
vulnerable to victimization because of impairment due to his or her use (e.g.,
psychopharmacological violence), due to economic crimes committed to support drug use
(e.g., economic-compulsive violence), and individuals working in illicit markets are
vulnerable because they often carry large sums of money or drugs (e.g., systemic
violence) (Oser, Money, Staton-Tindall, & Leukefeld, 2009; Weiner, Sussman, Sun, &
Dent, 2005). Therefore, individuals who use drugs – independent of gender – may be
perpetrators or victims of violent behavior for reasons related to the
psychopharmacological, the economic compulsive, or the systemic contexts of drug use
(Boles & Miotto, 2003; Goldstein, 1985; Goldstein, 1998; MacCoun, Kilmer, & Reuter,
2003).
The majority of research to date on substance use and violence has neglected to
consider varied contextual and demographic factors that distinguish rural residents from
urban- or national-samples. Justice-involved individuals are a vulnerable population
group that typically have higher incidents of substance use prevalence as well as higher
occurrences of violence, compared to the general population (Glaze & Herberman, 2011).
Moreover, justice-involved women from the economically distressed region of
Appalachia represent a unique subpopulation relative to generalized justice-involved
samples (Staton-Tindall et al., 2015). Specifically, the central Appalachian region is one
in which substance using women have significant barriers to treatment (Staton-Tindall,
Duvall, Leukefeld, & Oser, 2007; Victor, Kheibari, Staton, Oser, 2017) and the region
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has been disproportionately impacted by the prescription opioid crisis (Victor, Walker,
Cole, & Logan, 2017; Slavova et al., 2017).
Perspective of Appalachia
The Appalachian region is defined as a 205,000-square-mile region that is
connected by the Appalachian Mountains, which span from southern New York to
northern Mississippi (Appalachian Regional Commission [ARC], 2017). This region
includes all of West Virginia and portions of 12 other states, including: Alabama,
Georgia, Kentucky, Maryland, Mississippi, New York, North Carolina, Ohio,
Pennsylvania, South Carolina, Tennessee, and Virginia. Appalachia is further divided
into three sub-regions, which include the north, central, and southern regions..
Appalachia was defined as a distinct region primarily due to the nation’s interest in
addressing the social welfare needs of the inhabitants of the region. Generally, the
Appalachian region has been marked by endemic poverty, limited economic growth, poor
housing, greater health disparities compared to the general population, and limited
transportation and medical facilities (ARC, 2017). This study primarily focuses on the
eastern Kentucky counties that form the central Appalachian sub-region (ARC, 2017).
Racial minorities make up a marginal percentage of Appalachia’s population
(18.2%), but this number has increased by 16.2% since 2010 (ARC, 2017). Among
Appalachia’s minority populations, African Americans are the largest group (9.7%);
followed by Hispanics/Latinos (4.9%). The median age in Appalachia (40.9 years) is
higher than the national average (38.0 years). Education attainment falls behind national
averages in Appalachia; among Appalachian adults, 85.9% (U.S. 87.0%) have earned a
high school diploma, and 23.2% (U.S. 30.3%) have earned a bachelor’s degree (ARC,
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2017). Compared to the greater Appalachian region, Kentucky’s Appalachia has the
lowest education attainment of a bachelor’s degree at 13.6% (ARC, 2017).
Appalachia’s household income in 80% of the U.S. average ($62,299 vs 77,866),
and Appalachia’s poverty rate is higher than the U.S. average (16.7% vs 15.1%). Within
Appalachia, household income is lowest in central Appalachia (i.e., $48,706). Although
much of the Appalachian region has experienced outmigration, the southern Appalachia
has witnessed population growth of 4.7% from 2012 to 2016 (ARC, 2017). In
Appalachian Kentucky, 37 of the 54 counties are considered economically distressed,
with pockets of distress and at-risk counties throughout the region; thus, making this one
of the most underserved economic regions in the entire U.S. (ARC, 2017).
Women residents living in Appalachian Kentucky have contrasting
socioeconomic factors compared to men. For instance, Fiene (2002) notes that
Appalachian women of low socioeconomic status may have their opportunities for
educational and professional attainment curtailed by traditional gender roles within the
family and community. Gender roles and patriarchal formalities are not the only factor
that may impede central Appalachian women’s socioeconomic standing, as much of the
labor force in the region is dominated by male-oriented jobs (e.g., coal mining) (Miewald
& McCann, 2004). Although recent evidence suggests that employment in the extraction
industries are waning in favor of careers that require more education, progress has been
gradual, and the central Appalachian region still compares unfavorably to other regions
(ARC, 2017).
Appalachian women living in Kentucky have the highest high school drop-out
rate compared to all Appalachian regions (i.e., 24.0%) and to the U.S. national rate (i.e.,
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14.2%) (Haaga, 2004). In addition, women in Kentucky’s Appalachia rank lowest in
terms of post-secondary degree attainment (Brinley et al., 2018; Ferris, 2017). The
inequalities in occupation, income and status – all social determinants of health – faced
by Kentucky’s Appalachian women have been linked with a predisposition of poorer
health and quality of life (Marmot & Allen, 2014). Furthermore, considering the
intersectionality of social class and gender, the inequalities among Kentucky’s
Appalachian women – including inequalities within Appalachian women – may
predispose the most underserved populations to negative coping strategies, such as
substance misuse, and put them at-risk for victimization.
Economic Distress in Appalachia
The Kentuckian Appalachian region is one of the most economically distressed
regions in the nation (ARC, 2017). The ARC uses a socioeconomic classification system
that compares three-year averages of central Appalachian counties with the national
averages, based on measures of unemployment rates, per capita income, and poverty rates
(ARC, 2017). Against that backdrop, the region has witnessed improvements in poverty
rates – 31% in 1960 to 17.1% in 2015 – and the number of “high-poverty” counties (i.e.,
counties with poverty rates more than 1.5 the U.S. average) has declined from 295 in
1960 to 87 in 2015 (ARC, 2017). Several Kentucky Appalachian communities have
developed multifaceted economies, yet others still lack basic infrastructure, such as water
and sewage systems (ARC, 2017). This region has the largest number of counties that
rank in the lowest 10% in terms of socioeconomic status (Pollard & Jacobsen, 2015). In
addition, the region has the most rural counties, as compared to other Appalachian subregions, and the least number of inhabitants per square mile than the other sub-regions
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(ARC, 2017). The rural and isolated nature of Kentucky’s Appalachia have implications
for health disparities in the region. These health disparities are accentuated by limited
access to specialized healthcare services and an overall lack of a community-level
continuity of care (Halverson, Friedell, Cantrell, & Behringer, 2012).
Health Disparities in Appalachia
Many challenges persist despite the gradual economic progress made in select
areas of the Appalachian regions. Overall, the health disparities in Appalachia are greater
than those of the general U.S. population. Among the top ten leading causes of death in
the U.S., the Appalachian region has higher mortality rates for 7 of the 10 – heart disease,
cancer, chronic obtrusive pulmonary disease (COPD), injury, stroke, diabetes, and
suicide. Mortality due to poisoning, which includes drug overdose, is higher by a distinct
margin when compared to the general U.S. population (ARC, 2017; Borak et al., 2012).
Compared to the general U.S. population, Appalachian non-fatal health outcomes are
worse across several health domains, including, the number of physically unhealthy days,
the number of mentally unhealthy days and the prevalence rates of depression (ARC,
2017; Borak et al., 2012). In addition, risk factors that are associated with a host of health
problems are also higher in Appalachia; these include, obesity, smoking and physical
inactivity (ARC, 2017; Borak et al., 2012). Social determinates of health also play a role,
as low household incomes and high poverty rates reflect poor living conditions compared
to the general U.S. (ARC, 2017; Borak et al., 2012).
Drug overdoses and other forms of mortality due to poisoning are 37% higher in
Appalachia than in the general U.S. population. Behavioral health is also a concern, as
Major Depressive Disorder (MDD) in Appalachia is 16.7% higher than the national rate,
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and suicide rates are 17.0% higher than the national rate (ARC, 2017). In addition,
individuals living within Appalachian Region’s rural counties are 21 percent more likely
to commit suicide than those living in the Region’s large metro counties, and the
poisoning mortality rate is 40 percent higher in the Region’s rural counties than in its
large metro counties (ARC, 2017). Among all behavioral health indicators, 46% of
Appalachian counties are in the worst-performing national quintile for poisoning
mortality (ARC, 2017).
Individuals residing Appalachia demonstrate numerous needs and barriers to care,
including: 1) poverty and unemployment rates well above state and national averages; 2)
incarceration rates above the national average; 3) significant problems in accessing
affordable health care; 4) fewer health care providers per captia when compared to
national averages; 5) substance misuse and mortality rates well above national averages;
and 6) individual and community health indicators that are ranked nationally near the
bottom in most health-related metrics (e.g., chronic disease, substance abuse and
addiction, heart disease, diabetes, etc.). More recently, Kentucky ranks in the top five
among states that have been impacted by the opioid crisis. According to the Kentucky
Injury and Prevention and Research Center (KIPRC) approximately 30 out of every
100,000 people have died of a drug overdose in Kentucky from 2011 to 2014.
Drug Use-Related Health Disparities
The risk of contracting a chronic disease, such as HIV/AIDS or Hepatitis C,
increases significantly among individuals with a substance use disorder (SUD), among
injection drug users (IDU) and among individuals who experience a discontinuity of
health care (Perazzo, Reyes, & Webel, 2017). Much of the Appalachian region is
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considered by the CDC to be high-risk for HIV and HCV infections due to IDU (Van
Handel et al., 2016). Of note, Appalachian Kentucky was identified as having 8 of the top
10 at-risk counties, among the 220 nation-wide counties listed by the CDC (Van Handel
et al., 2016).
Among those engaging in IDU, research links low health literacy to the
contraction of a chronic disease or life-threatening infection, and there is evidence to
suggest health education mitigates this risk (Perazzo et al., 2017). That is, individuals
have been found to be unaware of the potential health risks that are associated with their
substance use (e.g., sharing syringes), although they may be aware of more direct health
risks (e.g., overdose). In addition, being introduced to injection behavior by a male
intimate partner has been found to increase high-risk injection (Morris et al., 2014). Most
experts agree that prevention, education, and harm reduction strategies are some of the
best tools to combating the potentially lethal effects of the current opioid crisis (Kolodny
et al., 2015).
Health and Social Factors for Justice-Involved Women
Women have been disproportionately affected by the policies and practices that
have contributed to mass incarceration (Alexander, 2012). Since 1980, the rate of
incarcerated women has increased by 336%; during the same period, men’s incarceration
rate has increased by 189% (Belenko, 2006). In terms of treatment needs, there are
generalities that can be made between justice-involved men and women. However, the
etiology and severity of treatment needs requires a gender-focused perspective. These
disparities are particularly pronounced for mental and physical health, vocational training
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and employment, familial issues, child care, and HIV and other infectious disease
(Belenko, 2006).
Recent major welfare reform – the Federal Personal Responsibility Act of 1996
(PRWORA) – has arguably increased the burden of employment for women. This
legislation, which includes Temporary Assistance for Needy Families (TANF),
established limits on the length of time that an individual is eligible to receive welfare
benefits, it requires employment in some cases, and denies benefits to felons with
substance use histories (Belenko, 2006). This is problematic for many justice-involved
women with substance use issues, because employment is a meaningful component of
recovery, and because women who use substances are more likely to have more extensive
trauma histories that significantly influence offending behavior, and as an extension,
negatively influence their employment opportunities (Moloney, van den Bergh, &
Moller, 2009). In addition, parenting responsibilities commonly are placed on women,
which may limit women’s ability to attend post-release treatment and attain additional
resources (Moloney et al., 2009).

Copyright © Grant Victor 2019
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Chapter II: Review of Relevant Literature
Substance Use Epidemiology in Appalachia
Compared to urban settings, rural areas have greater prevalence rates of substance
use among several substances, such as prescription opioids (Small, Curran, & Booth,
2010; Shannon, Havens, & Hays, 2010; Jackson & Shannon, 2012). Kentucky, and other
states with large rural populations (e.g., Kentucky, West Virginia, Tennessee) have
witnessed higher concentrations of prescription opioid morbidity, mortality, and
infectious disease in recent years (Keyes et al., 2014; Zibbell et al., 2015). Paulozzi and
Xi (2008) note that rural area non-medical use of prescription opioids (NMUPO) has
increased at a rate greater than three-fold when contrasted to metropolitan counties.
Along with the high prevalence of substance use, rural areas also have unique challenges
to providing recovery services. For example, rural communities are more likely to have
limited health service providers, and if recovery services are available, utilization of
services can be complicated by client transportation challenges (Victor et al., 2017;
Beardsley, Wish, Fitzelle, O’Grady, & Arria, 2003; Pullen & Oser, 2014).
Along with the unique challenges of providing substance use treatment in rural
communities, there are also regional (e.g., rural southeast) and demographic (e.g.,
vulnerable populations) differences in the prevalence of substance use disorders (SUD)
and the need for services (Oser et al., 2016; Varga & Surratt, 2014; Shannon, Havens,
Mateyoke-Scrivner, & Walker, 2009). For instance, NMUPO is more prevalent in the
southeastern rural areas of the U.S., and rural areas have also beheld a pronounced
increase in injection drug use (IDU) in recent years (Reifler et al., 2012; Staton-Tindall et
al., 2015b). Havens and colleagues (2006) found that the high rate of opioid prescriptions
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in rural Kentucky was correlated with regions that were classified as economically
distressed, which was operationally defined as poverty, fewer local treatment resources,
and higher rates of disability.
In rural Kentucky communities, substance use remains a growing public health
concern, with specific emphasis placed on NMUPO, heroin, and co-occurring IDU and
infectious disease (Keyes et al., 2014; Staton-Tindall et al., 2015b; Havens et al., 2011).
This region ranks among the highest in the country for rates of prescription drug misuse,
and rural residents have been found to be significantly more likely to misuse prescription
drugs as compared to urban residents (Young, Havens, & Leukefeld, 2010). In recent
years, the rise in IDU in the Appalachian region has elevated the public health risk. In
Kentucky, by 2002 approximately 16% of self-reported drug users indicated having ever
injected any drug (Christian, Hopenhayn, Christian, McIntosh, & Koch, 2010; Young &
Havens, 2012). Injection prevalence rates (44.3%) in Appalachian Kentucky have
increased considerably since the mid-2000’s and are higher among samples of opioid
users (Havens et al., 2007; Staton-Tindall et al., 2015b).
Patterns of Substance Use Among Women
The past three-decades of addiction research has revealed gender differences in
the health consequences of drug use, in the physiological responses to drug use, clinical
correlates of drug use, and in the patterns of both the administration of drugs and the
general use (Ashenberg-Staussner & Brown, 2002; Tuchman, 2010). Gender differences
have been reported in the types of substances used and patterns of drug use over one’s
lifespan (SAMHSA, 2017). National survey data (SAMHSA, 2017) shows that illicit
drug use (e.g., marijuana, cocaine, psychotherapeutics) among individuals over the age of
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12 was more common among men (11.5%) compared with women (7.3%) and that men
were more likely to report alcohol use (57.1%) than women (47.5%).
Gender differences emerge when investigating the patterns of illicit and licit
substance use. Generally, women begin self-administering licit and illicit substances at
lower doses compared to men. However, women’s use generally escalates to dependence
more quickly, as compared to men. In addition, gender disparities in substance use
prevalence is demonstrated by the striking data regarding prescription opioid use among
women. That is, there has been a 400% increase in deaths related to prescription opioid
overdoses, relative to the 265% increase in deaths among men; although, men continue to
have higher rate of prescription opioid deaths (Dart et al., 2015). Given the rise in
NMUPO in the past decade, researchers have begun to identify trajectories of drug use.
Back and colleagues’ (2011) describe the accelerated progression of OUD among
women by focusing on several biopsychosocial elements. These gender differences in
physiology (i.e., metabolic rate, gastric dehydrogenase, hormonal fluctuations) and in
society (i.e., adverse social consequences) can place women at increased risk of
experiencing negative health consequences as a result of their OUD (Greenfield, Back,
Lawson, & Brady, 2010). The empirical findings of gender-specific correlates of
NMUPO are consistent with previous research concerning other drugs of misuse
(Tuchman, 2010), as women appear to have different reasons for engaging in drug use,
accelerated progression of addiction, and complex health and mental health-related
concerns (McHuegh et al., 2013).
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Patters of Substance Use among Rural Appalachian Women
One population group that is affected at a greater proportion by the mentioned
rural drug trends are women; more specifically, economically disadvantaged rural women
(Staton-Tindall et al., 2015a; Staton-Tindall et al., 2015b; Browne et al., 2016;
Appalachian Regional Commission, 2017). Many of these women have been incarcerated
for drug offenses, particularly as sentencing has changed (Mumola and Karberg 2006).
Though initially public health advocates drew attention to the adverse health effects of
incarceration itself (Massoglia 2008), more recent research has stressed the health risks
that may occur upon reentry (Cook et al. 2005; Fogel et al. 2014).
Conditions related to economic distress increases the likelihood that individuals
from Kentucky’s Appalachian region will have low social capital, greater health
disparities, and limited environmental resources (Marmot & Bell, 2009). For drug-using
women in central Appalachian Kentucky, the economic and substance misuse problems
in the region are compounded by co-occurring mental and physical health concerns, low
health literacy regarding drug misuse, and the scarcity of treatment centers and/or
resources (Snell-Rood, Staton-Tindall, & Victor, 2015; Havens et al., 2006). Moreover,
these social determinates of health increase the likelihood of numerous health issues;
including among others, substance misuse and co-occurring related health issues (Varga
& Surratt, 2014; Webster et al., 2006).
Background on Substance Use and Violence
The relationship between substance use and violence has been given considerable
empirical attention. Current research has been primarily suggestive rather than conclusive
(Goldstein, 1998; Weiner, Sussman, Sun, & Dent, 2005). Evidence suggests that those

16

who use alcohol and drugs are commonly non-violent (Fagan, 1990); although, there is
empirical support to suggest alcohol use, and to a lesser degree substance use, has been
found to be present in both offenders and victims of violent acts. Substance use occurs in
a myriad of conditions; including, the environmental, the social, and the cultural contexts
that influence the potential for exposure to violence (Weiner et al., 2005). Certain
substances have been linked with a greater likelihood of violence; such as, alcohol and
illicit stimulants (e.g., amphetamines and cocaine) (Boles & Miotto, 2003; Goldstein,
1998; Goldstein, 1985; Oser et al., 2009). Furthermore, violence has been found to occur
in various phases of drug use, including acute intoxication, acquiring or distributing
drugs, and during episodes of drug induced psychosis and paranoia (Boles & Miotto,
2003; Goldstein, 1998).
It is also important to consider neurobiological factors involved in violence,
although there is no evidence to date that suggests these factors cause violence (Boles &
Miotto, 2003). The current understanding of how neurobiology is associated with
aggression is centered on monoamine neurotransmitters (i.e., serotonin, dopamine and
norepinephrine). That is, researchers believe that alterations in these neurotransmitters are
correlated with violent behavior. Broadly stated, these neurotransmitters are involved in
behavioral regulation. Abnormal serotonergic activity has been correlated to
psychological disorders and aggression (Kyes, Botchin, Kaplan, Manuck, & Mann,
1995), as well as being predictive of impulsive behavior, depression, and anxiety
(Robbins & Dailey, 2017; Higley & Linnoila, 1997).
Acute alcohol consumption causes a release of serotonin, and among a subset of
individuals with alcohol use disorder, baseline serotonin activity is lower compared to
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control groups (Higley & Linnoila, 1997). Therefore, the association between alcohol and
violence may be mediated by the neuroactivity of serotonin (Duke, Bègue, Bell, &
Eisenlohr-Moul, 2013). Dopamine and norepinephrine have been linked to reward cues
(e.g. environmental triggers) and multiple behavioral processes; such as, attention,
arousal and vigilance (Duke et al., 2013).
Endocrinological interactions have also been found to possibly play a role in
aggressive behavior (Boles & Miotto, 2003). Elevated levels of the sex hormone
testosterone have been correlated with violent behavior. In studies comparing violent and
nonviolent participants, among an array of study samples, those with higher blood
testosterone levels were consistently in the violent group (Brooks & Reddon, 1996).
More generally, “top-down” control systems in the prefrontal cortex fail to modulate
aggressive behavior when there is insufficient serotonergic facilitation (Siever, 2008).
The hypothalamus-pituitary-adrenal (HPA) axis also plays a key role in both substance
use behaviors and violent aggression, and these systems are influenced by regulatory
action found in the prefrontal cortex. Such that, a hyper-responsive arousal system,
including the amygdala, can affect evaluations of threat while also drive compulsory
substance use (Siever, 2008).
Theoretical Perspective: Goldstein’s Tripartite Conceptual Framework
In 1985, Goldstein first published his tripartite conceptual framework (Table 1),
which posited three pathways by which the use of controlled substances may influence
interactions with violence: 1) psychopharmacological pathways; 2) economic-compulsive
pathways; and 3) systemic pathways. The psychopharmacological pathway theorizes that
the altered psychological and physical effects of drug use lead to agitation, aggression,
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impulsivity, and cognitive impairment, increase the risk for violent behavior; along with
impairing decision-making and communication skills needed to avoid violence. The
economic compulsive pathway theorizes that obtaining illicit substances often entails an
individual to produce the capital to make a purchase; therefore, during a robbery or a
similar incident, violence may be used as a mean expedite the process, or for the purposes
of risk-aversion on part of the perpetrator. The systemic pathway theorizes that disputes
within illegal markets, such as the drug trade, can lead to violence to resolve conflicts
over “turf”, and/or for coercion and power.
Drug/Violence Relationship
Psychopharmacological

Definition
Physical and psychological effects of
controlled substances on violence

Economic-compulsive

Violence as the means for financing illicit
drug use (e.g., assault during a robbery)
Violence emerging from disputes within
illegal markets/informal economies (e.g.,
drug dealing or sex work in exchange for
drugs)

Systemic
Goldstein (1985)

Figure 1: Goldstein’s tripartite conceptual framework.
Literature applying the Goldstein (1985) framework has identified that urban men
and women contrast in their experiences of violence in association to their substance use.
Goldstein et al. (1988) initial study of his conceptual framework was conducted in New
York City amid the crack cocaine epidemic. In this seminal study, Goldstein et al. (1988)
worked alongside law enforcement to identify 218 drug-related homicides. In this
sample, 17% were classified as psychopharmacological, 4% were classified as economic
compulsive, and 75% were classified as systemic, while 7% were considered
“multidimensional.”

19

Among urban samples, men have been found to have a greater likelihood to
perpetrate violence when under the influence of greater volumes of drugs (Goldstein,
Brownstein, & Ryan, 1988; Goldstein, Brownstein, Ryan, 1992; Weiner et al., 2005).
However, under similar conditions, women have been found to be at a greater risk for
victimization of violence in association to their drug use (Oser et al., 2009). To date,
there has been limited application of Goldstein’s (1985) framework on rural incarcerated
women; in addition, it is unclear how rural incarcerated women’s substance use and
violence would be situated within this framework, and to what extent this framework is
associated with infectious disease and mental health among incarcerated women.
In addition to Goldstein’s (1985) conceptual framework, over the past three
decades feminism scholarship has developed a strong body of literature that has informed
the modern understanding of women’s configuration within the criminal justice system
(Chesney-Lind, 2006; Renzetti & Goodstein, 2000). Feminist criminology was developed
across the late 1960s to early 1970s, as a response to the general lack of diversity and
discrimination in the study of criminal justice research and the fundamental features of
the “backlash political agenda” – racism and sexism (Chesney-Lind, 2006).
In response, feminist criminologists centered the foci of their scholarship and
research on race/gender/punishment nexus. This meant advocating against the oppressive
and racist nature of the criminal justice system and its disproportionately punitive nature,
especially with respect to African American women (Chesney-Lind, 2006). Moreover,
feminist criminologists challenged the mischaracterization(s) of women in criminal
justice theory and research. These efforts in advocacy and scholarship have brought forth
meaningful social change and advancement of policy. Women’s victimization,
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particularly domestic violence, began to be defined and criminalized after an extended
period of neglect due to the androcentric authority over the discourse within the criminal
justice system (Chesney-Lind, 2006).
Feminist criminologists argue that one of the most comprehensive case studies in
the race/gender/punishment nexus is the “war on drugs.” This called for an increase
attention to the documentation and discussion of women in crime, with less emphasis on
“victimology,” and more so on the gender-specific pathways to criminal involvement
(Chesney-Lind, 2006). Formative scholarship and research followed that began to
identify how violent victimization shaped women’s drug use and criminal behavior,
especially in underserved communities (Burkhart, 1976; Chesney-Lind & Rodriquez,
1983; Chesney-Lind & Shelden, 2013; Gilfus, 1993). And the attention is surely still
relevant to the race/gender/punishment nexus. Current feminist advocacy and
scholarship, such as the #MeToo movement, has begun to develop a literature base with
themes relevant to gender-based violence and justice (Wexler & Robbennolt, 2019).
Psychopharmacologic Violence among Women in Community Populations
McCoy et al. (2001) analyzed how an individual’s experience in ever observing
violence, perpetrating violence, or victimized by violence based on their drug use status
(i.e., chronic drug users (CDUs) versus non-chronic drug users (NCDUs)). This study
used a snowball sample that was comprised of community members in Miami, Florida.
For their analyses, the authors used chi-square tests and logistic regression models. They
found that among CDUs and NCDUs, women were significantly less likely to be
observers (p < .001) and perpetrators (p < .001). Gender was also a significant predictor
in the regression models. Compared to women, men were significantly more likely to

21

observe someone beaten (OR = 3.07; CI = 2.26-4.14, p < .001), shot (OR = 2.28; CI =
1.81-2.87, p < .001), robbed (OR = 2.77; CI = 2.18-3.53, p < .001), or killed (OR = 2.17;
CI = 1.72-2.74, p < .001). Men were also significantly more likely to perpetrate a beating
(OR = 3.25; CI = 2.54-4.16, p < .001), a shooting (OR = 1.68; CI = 1.22-2.31, p < .01), a
robbery (OR = 2.13; CI = 1.56-2.91, p < .001), or a rape (OR = 5.56; CI = 1.19-25.64, p <
.05); however, women were significantly more likely to be victims of rape (OR = 0.06;
CI = 0.04-0.09, p < .001).
Overall, the regression models suggested that female CDUs were at greater risk
for violence victimization compared to female NCDUs. Of note, female CDUs and
NCDUs were both found to be at greater risk for violent victimization compared to men
(p < .01). The findings in this article suggest that drug use severity is a major factor in the
incidents of violence one is exposed to, as well as a strong predictor of different types of
violent acts. However, the authors stressed that the linkages found in this study between
drug use and violence are more indicative of a network interacting processes, rather than
causal processes.
Busch-Armendariz et al. (2010) compared victims' sexual assault experiences
based on whether the perpetrators were or were not using alcohol or drugs during a
sexual assault. This study used a statewide survey sample of Texas residents via the
Health Survey of Texans: A Focus on Sexual Assault. The analyses conducted included
descriptive tests, cluster analysis, and logistic regression models. The outcome variables
included variables of violence (i.e., slapping, hitting, kicking, biting) that occurred
concurrently with sexual assault, and variables of events (i.e., how many days a
participant had to take time off work, school, home, or recreational time). The
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independent variables included the alcohol and/or drug use by victim at the time of the
assault, alcohol and/or drug use by perpetrator at the time of the assault, race/ethnicity,
and the victims’ relationship to the perpetrator.
Findings relevant to the perpetrators’ alcohol and/or drug use indicated that 38.8%
used at the time of the assault. Moreover, victims’ alcohol and/or drug use at the time of
the assault was reported at 13.0%. The logistic regression results indicated that for
concurrent assault outcomes, the use of alcohol and/or drugs by the perpetrator
significantly increased the likelihood of intercourse or penetration (OR = 3.99, p = .002),
violence (OR = 3.92, p = .021), threat to harm or kill (OR = 3.14, p = .016), and physical
injury (OR = 2.64, p = .038). In terms of the post-assault outcomes, the perpetrators’ use
of alcohol and/or drugs significantly increased the likelihood of the victim taking
recreation time off (OR = 4.17, p = .004) and at least one day off recreation (OR = 3.27, p
=.016). The findings from this article suggest that a perpetrators’ use of alcohol or drugs
at the time of a sexual assault places the victim at a greater likelihood for further physical
injury, and a loss of time from a multitude of life events. Also, the impact of the
psychopharmacological pathway is highlighted in this study given that the relationship to
the perpetrator, the location of the sexual assault and the race/ethnicity of the victims did
not affect the findings.
Afifi et al. (2012) examined the relationship between perpetration and
victimization of physical and sexual IPV, and substance use disorders (SUDs) in the past
year by using national-level epidemiological survey data. The sample was stratified by
sex and used a four adjusted logistic regression models. The substances that were
significantly associated with victimization of IPV, included alcohol (AOR = 0.33; CI =
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0.24-0.44), cocaine (AOR = 0.28; CI = 0.10-0.80) and cannabis (AOR = 0.49; CI = 0.290.81). These results indicate that women with alcohol, sedative/tranquilizer, cocaine, and
cannabis SUD in the past year were significantly less likely to perpetrate IPV compared
to men with the same SUDs in the past year. Female victims of IPV were also
significantly less likely to have alcohol, cocaine, and cannabis SUD in the past year
compared to male victims of IPV.
Kramer et al (2012) examined how drug use affected physical victimization
among a sample of rural residents in Arkansas, Kentucky and Ohio. A series of logistic
regression models found that several factors significantly increased women’s' risk of
violence victimization in the past year. For instance, compared to women over 41 years
old, women aged 23 to 41 were significantly more likely (OR = 3.88; CI = 1.18-12.71) to
experience IPV. Substance use also significantly identified risk for women; such that,
alcohol misuse/dependence (OR = 3.76; CI = 1.59-8.88), cocaine abuse/dependence (OR
= 3.09; CI = 1.15-8.30), methamphetamine abuse/dependence (OR = 2.93; CI = 1.068.06), and the number of drugs used (OR = 0.74; CI = 0.60-0.92) increased the likelihood
of being a victim of IPV among this sample of rural women.
Lee et al (2010) examined the association of both perpetrators' and victims'
substance use with victim outcomes. The researchers utilized a snowball sampling
technique to recruit 114 battered women to conduct phone interviews in the following
metropolitan areas: 1) Pittsburgh (35%); 2) San Jose (28%); 3) Dallas (19%); and 4)
Minneapolis/St. Paul (18%). The two outcome measures were defined as, victims'
physical injury, and victims' functional impairment following the violent incident.
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Substance use by both perpetrators and victims was not significantly associated to
increased risk of victims' physical injuries. However, Lee and colleagues (2010) did find
a significant association between victims' substance use and their functionality following
an IPV incident. That is, compared to those who reported no substance use by perpetrator
or victim, the group where substance use by a perpetrator and victim was entered, R2 was
significantly increased from .32 to .40 (p < .05). Meaning, this finding suggests that when
perpetrators and victims both are involved in substance use at the time of a violent
incident, the victim is more likely to have greater functional impairment versus a control
group.
Psychopharmacologic Violence among Women in Substance Use Treatment
Schumm et al (2011) tested a conceptual model that integrates individual and
relationship pathways of IPV, to examine the IPV risk factors among a sample of 277
women entering substance abuse treatment. To qualify women must have had a
relationship with a male partner. Participants were questioned about their partners across
four domains, and these domains also functioned as the independent variables for this
article, they included: 1) antisociality/generalized violence; 2) heavy alcohol or drug use;
3) relationship adjustment; and 4) psychological and physical IPV. The primary outcome
variables were physical and psychological IPV by gender. A structural equation model
(SEM) was used to test pathways from latent predictor variables to the outcome variables
(i.e., IPV). Results revealed several statistically significant pathways of IPV.
Partner's antisociality/generalized violence showed a direct positive association
with her or his own perpetration of IPV (Female psychological IVP = R2 = .25, p < .001;
Female physical IPV = R2 = .29, p < .001; Male psychological IPV = R2 = .21, p < .001;

25

Male physical IPV = R2 = .25, p < .001). A negative association was found between both
partners' relationship adjustment and psychological IPV (Female psychological IPV = R2
= -.24, p < .001; Male psychological IPV = R2 = -.23, p < .001). The findings regarding
substance use and IPV were mixed. A positive relationship was found between female
drug use and female physical IPV (R2 = .18, p < .001), yet male heavy drinking had a
positive association with male psychological IPV (R2 = .12, p < .05).
Additional tests were conducted to examine indirect pathways to IPV. Female
heavy drinking is shown to exhibit a positive indirect effect on female psychological IPV
via relationship functioning (standardized indirect effect = .04, p < .01). Female heavy
drinking also exhibited a positive indirect effect on female physical IPV via the pathway
involving relationship functioning to psychological IPV (standardized indirect effect =
.03, p < .01). Collectively, the findings from Schumm et al (2011) show the pathways to
IPV are complex and at times gender-specific; more specifically, both partners'
antisociality/generalized violence, substance use, and overall relationship adjustment are
key to understanding IPV among women entering substance misuse treatment.
El-Bassel et al (2005) examined whether the frequent drug use increased the
likelihood of subsequent sexual or physical IPV and whether IPV increases the likelihood
of subsequent frequent drug use. This article used a random sample of 416 women who
were recruited from a methadone maintenance treatment facility in New York City, New
York. This study utilized propensity score matching and logistic regression analyses to
test three hypotheses, they included: H1) that frequent drug use increases the likelihood of
IPV; H2) that IPV increases the likelihood of subsequent frequent drug use; and H3) the
relationship between frequent drug use and IPV is reciprocal.
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For hypothesis 1, women who used crack at least once a week were more than 4
times as likely to report physical or sexual IPV compared to women who did not report
using any drugs or binge drinking (OR = 4.4; 95% CI = 2.1-9.1; p < .01); similar results
were found for marijuana (OR = 4.5; 95% CI = 2.4-8.4, p < .01). Results also indicated
that women who reported cocaine use did experience higher rates of IPV, but this result
did not reach statistical significance. For hypothesis 2, women who reported physical or
sexual IPV were more likely than women who did not report IPV to indicate frequent use
of heroin (OR = 2.7; 95% CI = 1.1-6.5, p < 0.4). Near significant findings were found for
an increased likelihood of frequent crack use (p < .06), marijuana use (p < .07), and
cocaine use (p < .11). Therefore, hypothesis 3 was not supported at a 95% level of
confidence, yet hypothesis 1 and 2 were indicative of crack and marijuana use;
suggesting that the relationship between frequent drug use and IPV is bidirectional and
varies by type of drug.
Chermack et al (2002) examined the relationship between violence severity and
alcohol and cocaine consumption among a sample of substance abuse treatment clients (n
= 125 women, n = 125 men) in Michigan. Repeated measures ANOVAs and regression
analyses were conducted to test the relationship between violence severity and alcohol
and cocaine use. Both general alcohol and cocaine use patterns (on days not involving
significant interpersonal conflict) [F (2,208) =15.11, P<0.001], as well as alcohol and
cocaine use on the day of the violent incident F (2,208) =3.38, P<0.05], were associated
with violence severity. Regression analyses revealed that race (β = 0.23), age (β = -0.16),
and both general drinking (β = 0.28) and cocaine use patterns (β = 0.18) were positively
associated with violence severity for the most severe violent incident reported. Similarly,
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regression analyses focusing on alcohol and cocaine use on the day of the most severe
incident revealed that higher drinking levels, younger age, minority status, and the
interaction of alcohol and cocaine use have a significant positive associated with violence
severity. Chermack et al (2002) posited that these findings suggest the need for
implementation of routine screening and intervention protocol aimed at violence-related
problems in substance abuse treatment settings.
Schneider et al. (2009) examined the prevalence rates and correlates of IPV
victimization among a national sample of men and women in substance abuse treatment.
This article used secondary data from the National Treatment Improvement Evaluation
Study (NTIES) where men (n = 4,459) and women (n = 1,774) were recruited across 71
treatment sites between July 1993 and November 1994. Bivariate relations between
demographic, substance use, and child abuse variables and lifetime IPV victimization
were tested separately by gender. Demographic, substance use and child abuse variables
that were significant (p < .05) at the bivariate level were included as covariates in the
logistic regression model. Results indicate that nearly 1 in 2 women and 1 in 10 men
reported lifetime victimization by an intimate partner.
Lifetime IPV victimization was reported by 46.7% of women (n = 828) and 9.5%
of men (n = 422). Bivariate logistic regression results indicated that women at or above
the median age of 32 (OR = 1.37; CI = 1.12-1.64, p < .01) women without a high school
diploma or GED (OR = 1.25; CI = 1.04-1.51, p < .001), and women who had been
married (OR = 1.91; CI = 1.57-2.31, p < .001) were more likely to report lifetime IPV
victimization; Black women were less likely (OR = 0.67; CI = .54-.83, p < .001) to report
IPV victimization relative to non-Black, non-Hispanic women. Relative to women
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entering treatment for drug abuse only, women entering treatment for alcohol abuse (or
alcohol and drug abuse) were more likely to report IPV victimization (OR = 1.55; CI –
1.28-1.88). Cocaine, “crack”, heroin, and marijuana use did not correlate to IPV. The
admission of drug use was significant, as injection drug use was associated with IPV
victimization in bivariate analyses (OR = 1.47; CI = 1.21-1.79).
In addition, women with a history of child physical (OR = 4.61; CI = 3.45-6.17)
or sexual abuse (OR = 2.48; CI = 2.00-3.08) had greater odds of experiencing
victimization by an intimate partner. In multivariate analyses with women, IPV
victimization was associated with greater odds of reporting symptoms of anxiety (aOR =
1.58; CI = 1.27-1.96, p < .001), depression (aOR = 1.54; CI = 1.21-1.96, p < .001), and
psychosis (aOR = 1.51; CI = 1.22-1.87, p < .001) as well as suicidal ideation (aOR =
1.69; CI = 1.37-2.09, p < .001) and lifetime suicide attempt (aOR = 1.73; CI = 1.39-2.16,
p < .001). After adjusting for covariates, IPV victimization was also associated with
greater odds of reporting recent circulatory, neurological, and bone or muscle problems
and an STD among women. These findings build on the understanding that IPV among
women in substance misuse treatment warrants a nuanced examination, and one that
expects variation by gender.
Psychopharmacologic Violence among Criminal Justice-Involved Women
Stuart et al. (2008) analyzed the role of illicit substance use in IPV and examined
the potential influence of overall and specific illicit substance use on IPV perpetration in
men and women arrested batterers and their relationship partners. The sample consisted
of males (n = 271) and females (n = 135) who were at least 18 years-of-age, who were
arrested for violence, and who were court-referred to batterer intervention programs. The
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analytical plan of this study included several analyses to test whether the addition of drug
use variables significantly increased the model's ability to predict psychological and
physical victimization. First, structural equation models (SEM) were constructed to
examine model fit for men and women. Two sets of analyses were used in SEM; the first
set examined how overall drug use predicted IPV relative to other variables, and the
second set examined how specific drug use (i.e., marijuana, sedative, and stimulant)
became separate predictors of IPV. For both sets, confirmatory factor analyses (CFA)
were conducted to assure the factor structures adequately describe latent variable
indicators, to fit the CFA into a larger structural regression model and to involve
supplementary analyses by comparing models in which the drug use variables have direct
paths to victimization with one in which those paths did not have direct effects.
Demographic analyses found that use of any drug by female partners of male
perpetrators (33%) was substantially lower than that for male perpetrators (54%), female
perpetrators (59%), and male partners of female perpetrators (56%). Four of the five
significant drug-to-victimization paths varied by gender. For male perpetrators, the paths
from their marijuana use (.10, p < 0.05) and stimulant use (.10, p < 0.05) to their own
physical aggression was significant. For female perpetrators, none of the drug use
variables showed any significant effects on the aggression variables. Male perpetrator's
reports of their female partners’ sedative use (.08, p < 0.05) were associated with their
reports of their partners’ psychological aggression, whereas the male’s reports of their
partners’ stimulant use (.07, p < 0.05) were associated with their reports of their partners’
physical aggression. Female perpetrators’ results showed that only their reports of their
partners’ stimulant use were a significant predictor; where, male partner stimulant use

30

was associated with both his psychological (.15, p < 0.05) and physical aggression (.08, p
< 0.05). These results provide further evidence that drug problems by both partners may
be important in the evolution of aggression.
Sheehan et al. (2013) aimed to compare men and women based on the presence of
drugs when considering deaths that were attributable to homicides and suicides. Data
were used from the Colorado Violent Death Reporting System (COVDRS), which is
conducted by the Colorado Department of Public Health as a participant in the National
Violent Death Report System (NVDRS) and funded by the Centers for Disease Control
and Prevention. Data spanned from 2004-09 and included N=5,791 violent death victims
among individuals aged 18 years and older. Researchers used a logistic regression to
investigate the associations between the presence of substance use (i.e., alcohol,
amphetamines, antidepressants, cocaine, marijuana, and opiates) and type of death (i.e.,
homicide or suicide). Comparisons were also made between individuals' sex, age,
race/ethnicity, and educational attainment. The type of violent death was used as the
outcome variable and it was coded as 1 = homicide and 0 = suicide.
The results underscored strong associations between drug use and type of violent
death, as well as significant gender differences. Compared with suicide decedents,
homicide decedents are significantly more likely to test positive for amphetamines (OR =
1.79; CI = 1.34-2.39], marijuana (OR = 2.03; CI: 1.60-2.58) and cocaine (OR: 2.60 = CI:
2.04-3.31) and are less likely to test positive for opiates (OR = 0.27; CI = 0.18-0.39) and
antidepressants (OR = 0.17; CI = 0.10-0.28). For women, only cocaine indicated a
significant association with homicide as it increased the odds of death by homicide than
by suicide (OR = 1.96; CI = 1.11-3.45, p < .05). The presence of antidepressants in
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women increased their odds of death from suicide compared with homicide by ~12 times.
Drugs associated with homicide (marijuana, cocaine and amphetamines) are stronger
among males, while drugs associated with suicide are stronger among females
(antidepressants and opiates). Taking these differences into consideration may allow for
targeted interventions to reduce violent deaths.
Psychopharmacologic Violence among Women in Mental Health/Medical
Populations
Gilbert et al. (2012) examined the temporal and bidirectional associations
between different types of substance use and different types of IPV among a sample (N =
241) of urban women receiving emergency room care. The sample was collected from a
New York City Emergency Department in the Bronx, where 90% identified as Latino or
African American, and nearly one-third lived below the poverty level. This article applied
a theoretical framework – the ecological perspective – to allow the researchers to
conceptualize the multilevel risk and protective factors that were associated with
substance use and IPV among women.
This longitudinal study was organized in three waves; such as, wave 1 was
baseline, wave 2 was at the 6-month follow-up mark, and wave 3 was at the 12-month
follow-up mark. This authors of this study outlined two hypotheses for their study.
Hypothesis 1 aimed to use of different illicit drugs and binge drinking at Wave 1
increases the subsequent likelihood of experiencing different types of IPV at subsequent
Wave 2 (6-month follow-up) and/or Wave 3 (12-month follow-up), after adjusting for
sociodemographic, multilevel risk and protective covariates, and the baseline indicator of
IPV outcome using modified Poisson regression and propensity score weighting.
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Hypothesis 2 aimed to investigate if the experiences of different types of IPV at Wave 1
increases the likelihood of subsequent use of different drugs and binge drinking at Waves
2 and/or 3, after adjusting for sociodemographic, multilevel risk and protective
covariates, and baseline indicator of substance use outcome using modified Poisson
regression and propensity score weighting.
Hypothesis 1 was partially supported with significant findings. At Wave 1, results
indicated that 43.2% of women reported using illicit drugs within the previous 6-months.
Moreover, 33.2% reported marijuana use, 12.9% reported crack or cocaine use, and 7.5%
reported heroin use. At Wave 3, illicit drug use was reported at 33%, with marijuana
being the largest decrease in reported use – heroin, crack/cocaine, and other "hard drugs"
remained more consistent. The results from hypothesis one revealed several significant
results. Presented as risk ratios (RR), women who reported heroin use at Wave 1 were
about twice (RR = 2.1; CI = 1.2-3.6; p < .05) were more likely to report IPV and to report
injuries (RR = 2.7; CI = 1.1-6.5; p < .05). Compared to women who did not report
crack/cocaine use at Wave 1, women who reported crack/cocaine use at Wave 1 were
about twice (RR = 2.4; CI = 1.2-4.7; p < .05) as likely to report injurious IPV and about
twice as likely to report severe verbal abuse (RR = 2.01; CI = 1.2-3.3; p < .05).
Collectively, the use of “hard drugs” (i.e., heroin, cocaine and “crack” cocaine)
was found to increase the likelihood of experiencing all types of any IPV (RR = 1.6; CI =
1.1-2.4, p < .05), physical IPV (RR = 1.7; CI = 1.1-2.6), injurious IPV (RR = 3.0: CI =
1.4-6.4, p < .01). Hypothesis 2 was also partially supported with significant findings.
That is, women who reported sexual IPV at Wave 1 were nearly three-times more likely
to have reported the use of crack or cocaine (RR = 3.3; CI = 1.1-9.5, p < .05) and nearly
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twice as likely to report the use of “hard drugs” (RR = 2.4; CI = 1.2-4.8, p < .05) at
subsequent Waves. The findings in this study underscore the importance of understanding
the bidirectional ways that substance use and IPV interact. This study also describes the
importance of having substance use- and IPV-related screening tools that are specified to
ED settings.
Systemic Violence among Justice-Involved Women
Weir et al. (2008) examined the prevalence and correlates of IPV and other
violence (OV) among justice-involved women (N = 529) who were identified as being at
high-risk for HIV/AIDS. Women were eligible if they reported (a) being at least 18 years
old, (b) having been incarcerated in the past year or currently being on parole or
probation, and (c) engaging in HIV risk behavior (injection drug use, crack use,
intercourse with a male IDU, exchanging sex, or having had 10 or more sexual partners)
in the past year. Results indicated that 44% of this sample reported substance use in the
past 30-days. The substance use profile includes: alcohol (65.2%); marijuana (34.8%);
crack cocaine (30.0%); amphetamines (28.4%); heroin (24.0%); and cocaine (20.2%).
Among participants who reported substance use in the past 30-days, 15.7% reported IDU.
Substance use was significantly associated with IPV and OV. Specifically,
alcohol or marijuana use meant a participant was nearly twice as likely to be a victim of
IPV (OR = 1.85; CI = 1.02-3.36, p < .05), and the use of other drugs (i.e., crack cocaine,
cocaine, amphetamines, and heroin) revealed similar results (OR = 1.95; CI = 1.19-3.18,
p < .05). Injection drug use was also significantly associated with IPV (OR = 1.75; CI =
1.05-2.94, p < .05). Other violence (OV) was also associated with substance use; for
instance, alcohol and marijuana use (OR = 1.61; CI = 0.79-3.30, p < .05), other drug use
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(OR = 2.10; CI = 1.19-3.71, p < .05), and IDU (OR = 2.05; CI = 1.13-3.71, p < .05).
These results indicated that the risk of violence victimization, and subtypes of violence
victimization (IPV vs. OV) is identifiable based on the type of substance used. Therefore,
effective interventions must address the complexity of the drugs violence nexus, as well
as the host of other non-substance-use-related associations of violence as identified in this
article.
Systemic Violence among Illegal Economy Working Women
Surratt et al. (2004) examined how the subculture of violence impacts women
who work as sex workers in Miami, Florida. This article utilized a community-based
sample that was recruited by using targeted sampling techniques. Specifically, sex
workers that were crack cocaine- and heroin-using individuals were recruited through
street outreach and via an HIV-prevention research program. Participant interviews
included standardized instruments that focused several personal histories, including: 1)
drug- and sexual-related risk for HIV; 2) sex work; 3) violence; 4) childhood trauma; and
5) health status. Histories of childhood trauma (i.e. lifetime) and substance use (i.e., past
month and past year) were the independent variables, and violent victimization(s) was the
dependent variable.
The analyses included univariate and bivariate frequency, descriptive, and chisquare tests. The findings indicated that among this sample of sex workers, 75.4% were
currently using alcohol, 57.8% were currently using marijuana, 38.4% were currently
using cocaine, 74.4% were currently using crack cocaine, 19.4% were using heroin, and
13.8% were currently injecting drugs. Approximately half of the respondents reported
physical (44.9%) and/or sexual (50.5%) abuse as children, while nearly 40% experienced
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violence from clients in the prior year: 24.9% were beaten, 12.9% were raped, and 13.8%
were threatened with weapons. Consistent relationships between historical and current
victimization suggest that female sex workers experience a continuing cycle of violence
throughout their lives.
Economic-Compulsive Violence among Justice-Involved Women
Oser et al. (2009) sought to examine the drugs/violence nexus among rural felony
probationers (N = 800). Data for this study was obtained over a 3.5-year period where
probationers were recruited by trained interviewers in probation offices in Appalachian
Kentucky. Females were over-sampled at 30% to ensure adequate representation and to
facilitate a sufficient sample size for data analyses. In this study, violence victimization
was measured by either being “beaten up and/or someone using a knife or firing a gun at
the participant.” Violent perpetration was measured by either the participant “beating
someone else up and/or using a knife or gun on someone.” Independent variables
included demographic characteristics (i.e., gender, marital status, age, and education),
psychopharmacological measures (i.e., alcohol, cocaine/crack, and
amphetamine/methamphetamine), economic compulsive measures (i.e., engaged in crime
to pay for drug expenses, and number of lifetime arrests) and systemic measure (i.e.,
committed a weapons offense and ever sold or trafficked drugs in lifetime).
Two dependent variables were used, if the participant had been a victim of violent
crime (1 = yes; 0 = no) or ever committed a violent crime (1 = yes; 0 = no). Analyses
included tests of chi-square and one-way ANOVA to measure group differences, and a
series of binary logistic regressions were used to determine the impact the independent
variables had on being a victim of a violent crime. For group comparison, participants
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were grouped in four groups based on the following: 1) never been involved in violent
crime; 2) victim of a violent crime; 3) perpetrator of a violent crime; and 4) both victim
and perpetrator of violent crime.
Bivariate results indicated that females comprised 63.8% of the violent
victimization group, but only 27% of the violent perpetrator group (χ2 (3) = 66.57; p <
.001). Among the psychopharmacological measures, participants who were both a violent
perpetrator and a victim were more likely to define themselves as an alcoholic (χ2(3) =
27.16, p < .001), to have used cocaine/crack (χ2(3) = 47.79, p < .001), and to have used
any stimulant other than crack or cocaine (χ2(3) =56.74, p < .001). Among the economic
compulsive variables, an average of 12.7 lifetime arrests were found among participants
who were both a perpetrator and a victim, compared to 4.6 in the neither group, 7.0 in the
victim group, and 5.7 in the perpetrator group (F (3) = 14.97, p < .001). In addition,
participants who identified as both a perpetrator and a victim in a violent crime were
significantly more likely to have engaged in crime to pay for drugs and/or living expenses
(F (3) = 7.93, p < .001). Among the systemic variables, participants who were both
violent perpetrators and victims were most numerous among those who had ever
committed a weapons offense (χ2(3) = 36.56, p < .001). Nearly 62% of the both group
reported selling or trafficking drugs as compared to about two-thirds of the neither group
(40.2%) (χ2(3) = 34.68, p < .001).
The full multivariate model results for violent perpetration included the
demographic, psychopharmacological, economic compulsive, and systemic measures for
violent perpetration. For females, those with high school diplomas or GEDS were less
likely to be violent perpetrators (OR= 0.70; CI = 0.50-0.99, p < .05). Lifetime stimulant
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use predicted an increased likelihood of having ever committed violent crime (O.R. =
1.60; CI = 1.09-2.37, p < .05). The number of lifetime arrests was positively correlated
with having ever committed a violent crime across the lifespan (O.R. = 1.02; CI = 1.001.04, p < .05).
The full multivariate model results for violent victimization based on marital
status coefficient remained stable across the four models with married participants being
less likely to have been violently victimized in their lifetime. Participants who identified
as alcoholics (O.R. = 1.86; CI = 1.11-3.09, p < .05) and those who reported having ever
used stimulants other than crack or cocaine (O.R. = 1.91; CI = 1.30-2.80, p < .01) were
nearly twice as likely to have been subjected to violent victimization. A positive
significant association was found between criminal violent victimization and the number
of times an individual was arrested (O.R. = 1.05; CI = .74-1.48, p < .01). These findings
illuminate the unique components of rural violence. The multivariate analyses supported
the economic compulsive model among both perpetration and victimization of violence.
Disparate fields of study (i.e., sociology; public health; social work; psychology;
criminal justice) have provided evidence that women and men are involved in violent
events at similar rates, and that drug use often plays a critical role in these experiences.
For women, strong associations between drug use and violence have been found in recent
years. The current literature indicates that opportunities for involvement in drug-related
violence victimization occur within complex interactions between social and
environmental contexts. For many women, violent victimization typically occurs within
community settings or intimate relationships, and violent perpetrators are often known by
the victim. These experiences often place them in medical (e.g., emergency room), SUD
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treatment, and criminal justice (e.g., county jail) settings. Having said that, the magnitude
of drug use and co-occurring problems is considerably greater among justice-involved
women.
Although highly variable, the type of drugs used, and the severity of use were
associated with experiences of violent victimization. Among female victims, there is
support for the presence of psychopharmacological violence. Two drug classes were
highly prevalent in their associations with psychopharmacological violent victimization –
opioids (i.e., NMPO & heroin) and stimulants (i.e., methamphetamine/amphetamine and
cocaine). Economic-compulsive and systemic violence among women is also supported
by recent literature, albeit less so compared to psychopharmacological violence.
Although it is generally accepted that there is a relationship between drug use and
violent victimization, the direction of this relationship is less clear. In general, the
findings in the literature are mixed. There is evidence that drug use (El-Bassel et al.,
2005; Testa et al., 2003) and alcohol use may precede abuse by an intimate partner, or a
member of the community (Devries et al., 2014). In addition, curtailment of substance
use has indicated a reduced risk of subsequent victimization (Cohen, Field, Campbell, &
Hien, 2013). Conversely, there is evidence that experiencing IPV is related to later drug
use (El-Bassel et al., 2005), or that violent victimization and substance use may have a
bidirectional relationship. For example, a 2-year longitudinal study utilizing a nationally
representative cohort of women found that following a physical or sexual assault,
women’s alcohol and drug use increased, including among women with no previous
substance use and no prior victimization history. Moreover, women’s substance use was
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associated with an increased risk of experiencing a subsequent physical or sexual assault
(Kilpatrick et al., 1997).
Collectively, despite a high quantity of recent research investigating drug use and
violence among women, few studies have directly applied Goldstein’s (1985) conceptual
framework to a rural vulnerable population (i.e., justice-involved women). Moreover, no
studies to date have investigated how subtypes (i.e., psychopharmacological, economiccompulsive, and systemic) of drug-related violence may be associated with behavioral
health risk factors. It is important to examine justice-involved women from Kentucky
because compared to U.S. rates, the region of Appalachian Kentucky has high rates of
past-month illicit drug use (excluding cannabis) and high rates of incidents related to
poor behavioral health and infectious disease (SAMHSA, 2014).
Current Study
The current study will analyze existing data from a cohort of justice-involved
women from jails located in central Appalachia Kentucky. The substance misuse and
violence relationship among rural justice-involved women has largely been unexplored
by the current literature. Although research investigating substance use and co-occurring
mental health and infectious disease risk factors has been explored (Staton-Tindall,
2015a), it is unclear how the types of violent victimization experiences may shape these
risk factors. A fuller understanding the relationship between substance use and violence,
and how this relationship extends to a host of mental health and behavioral risk factors
for infectious disease may illuminate specific intervention points that could translate to
policy- and clinical-level action for rural justice-involved women. In addition, this
proposed study could inform Goldstein’s (1985) theoretical framework by providing
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novel drugs/violence nexus data related to justice-involved women, and by postulating
how behavioral health may be impacted by each theoretical domain – a concept that has
largely been unexplored within this theoretical framework (Goldstein, 1998).
This study will utilize deductive methods to test Goldstein’s (1985) tripartite
conceptual framework to extend previous research and to evaluate this framework
according to a unique and vulnerable population. The focus of Goldstein’s (1985)
tripartite conceptual framework will be placed on investigating how the current sample is
grouped (i.e., psychopharmacologic group; economic compulsive group; or systemic
group), and how these groupings are associated with selected health-related outcomes.
Three research questions will be explored in this study.
Research Questions and Hypotheses
Research Question 1: Can distinct drugs/violence nexus groups be predicted
based on psychopharmacological factors, economic compulsive factors, and systemic
factors among a sample of rural justice-involved women?
Ha1: There will be significant predictors of group membership across the three
predicted drugs/violence nexus groups and a greater prevalence of participants will be
observed in the psychopharmacologic group.
Research Question 2: What are the associations between mental health
symptomology and the predicted groups (i.e., psychopharmacologic; economiccompulsive; systemic) groups?
Hb1: Among each of the predicted groups, there will be a greater number of
significant associations between mental health symptomology and the
psychopharmacologic group.
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Research Question 3: What are the associations between behavioral risk factors
for infectious disease and the predicted groups?
Hc1: Among each of the predicted groups, there will be a greater number of risk
factors among the psychopharmacologic group, given that this grouping entails
participants directly administering drug use, thus increasing the likelihood of risk for
infectious disease.
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Chapter III: Methods
Data Source
Data for this study was obtained from a longitudinal project (National Institute on
Drug Abuse, [NIDA] 1R01-DA033866) called the Women’s Intervention to Stop
HIV/Hepatitis C (WISH). This project focused on high-risk drug use and risky sexual
practices among a randomly selected group of rural incarcerated women located in
Appalachian jails. To enroll in this study, participants had to meet the following
eligibility criteria: 1) National Institute on Drug Abuse (NIDA, 2010) modified Alcohol,
Smoking and Substance Involvement Screening Test (ASSIST) scores of four or greater
indicating the need for substance abuse intervention; 2) engaged in at least one high-risk
sexual practice in the 3-months prior to incarceration; 3) resided in designated
Appalachian county before incarceration; and 4) indicated a voluntary willingness to
participate in the study. The WISH study has been approved by the University of
Kentucky Institutional Review Board. Due to concerns regarding protecting the identities
of vulnerable participants, a federal certificate of confidentiality was obtained to further
ensure that privacy standards were upheld.
Procedures
All study recruitment and data collection procedures were approved by the
university institutional review board and protected under a federal Certificate of
Confidentiality. Drug-using women were recruited from three rural jail facilities located
in Appalachian counties. The jails were similar regarding size, female populations and
availability of programming and resources. Consent for participation in the project was
provided by all participants before study screening procedures. During the 32-month

43

study recruitment, 688 women were randomly selected from the target jails for study
screening.
Study screening took place in a large group room in the jail and included
measures to assess substance abuse (NM-ASSIST; NIDA, 2009), risky sexual practices
(Wechsberg, Craddock, & Hubbard, 1998), and voluntary willingness to participate.
Following the screening session, eligible women (n = 440) were invited to participate in a
more in-depth baseline interview within a period of 2 weeks to assess their substance
abuse history, risky sexual practices, history of substance abuse treatment, attitudes
toward the health care system and overall health. During the 2-week period between the
time of study screening and in-depth interviews, 40 women were released early.
Interviews were conducted with 400 women by female research staff from the local
Appalachian area, who were trained on human subjects protections and jail facility
policies and procedures prior to study implementation. Participants were paid $25 for the
baseline interview.
Measures
The current study proposes a quantitative design to examine theoretical factors
associated with substance use and violence based on the Goldstein (1985) tripartite
conceptual framework, to predict group membership within these theoretical concepts,
and to test for associations between the predicted groups and mental and physical health
factors. The Global Appraisal of Individual Need–Intake version (GAIN) is a
standardized instrument package administered for research purposes only, and intended
to support clinical decision-making for potential diagnoses, placement, treatment
planning, and service use (Dennis, Titus, White, Unsicker, & Hodgkins, 2003). This
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study used select subsections of the GAIN for measurement purposes, and specific
descriptions of those measures are described in the following sections. The GAIN-SPS
has been found to be highly reliable with adolescents and adults, with alphas ranging
from .80 to .90. Cronbach’s alpha for the current study is .89.
To measure substance use, this study used the Alcohol, Smoking, and Substance
Involvement Screening Test (ASSIST) (Humeniuk et al., 2008). This interview-based
instrument was developed by the World Health Organization (WHO) to screen across
substances. It consists of 8 questions that aid in identifying the level of substance userelated risk to help guide intervention. Among the current sample, the Cronbach’s alpha
for the ASSIST measure was .81. Each of the measures included in the multivariate
models are presented in Table 1.
Demographics
Demographic variables to be included will be age, marital status, education,
income, children status, housing, violence victimization, and drug use history. Age was
measured as an interval measure by number of years. Marital status was measured
categorically by asking the participants if they were currently with a partner (1 = Yes; 0 =
No). Education was measured continuously as the highest level of education attainment.
Income was measured continuously in dollars by asking, “During the six-months before
incarceration, what was your total income from all sources including work,
family/friends, government support, etc.?” Participants children status was measured
dichotomously (1 = Yes; 0 = No). Employment was measured nominally by asking
participants to report their last job prior to incarceration, values included; 1 = professional
& technical; 2 = manager and administer; 3 = sales; 4 = clerical or office work; 5 = craft
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and kindred; 6 = operative; 7 = transportation equipment operative; 8 = nonfarm laborer;
private household worker; 9 = private household worker; l0 = service worker; 11 =
farmer and farm manager; 12 = farm laborer; 13 = military service; 14 = fast food
industry; 15 = construction; 16 other. Housing was measured continuously by asking
“Number of days in the 6-months before incarceration were you homeless or had to stay
with someone else to avoid being homeless?” Chronic pain was measure by asking,
“Does participant have any chronic physical pain that has lasted longer than 3-months (0
= No; 1 = Yes)?”
Psychopharmacologic Variables
The psychopharmacologic variables were measured by using five continuous
substance use variables. These variables were taken from the NIDA-Modified Alcohol,
Smoking and Substance Involvement Test (ASSIST) (Humeniuk et al., 2008). Drug use
that was included in this study included prescription opioids, prescription stimulants,
prescription sedatives, heroin, methamphetamine and cocaine. The ASSIST scoring range
is as follows: 0-3 = low risk; 4-27 moderate risk; and 27+ high risk.
Participants were asked about their lifetime and past 3-months drug use prior to
incarceration. Questions 1 to 7 ask about drug use and related problems. Question 1 asks
about which substances have ever been used in the participant’s lifetime. Question 2 asks
about the frequency of substance use in the past 3-months to give an indication of the
substances that are most relevant to current health status and use patterns. Question 3
asks about the frequency of experiencing a strong desire or urge to use each substance in
the past 3-months. Question 4 asks about the frequency of health, social, legal or
financial problems related to substance use in the past 3-months. Question 5 asks about
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the frequency with which each substance has interfered with personal responsibilities in
the past 3-months. Question 6 asks if anyone has ever expressed concern about the
participant’s substance use in their lifetime, and how recently that occurred. Question 8
concerns IDU and asks whether the participant had ever injected any drug (Humeniuk et
al., 2008).
Economic-Compulsive Variables
The economic-compulsive component was measured using one continuous
variable and one dichotomous variable that targeted the extent to which drug-related
illegal activity occurred because of economic necessity. Participants were asked, “How
many days in the past 3-months prior to incarceration they engaged in illegal activities for
profit?” In addition, participants were asked, “In the past year, did you ever have sex with
a partner in exchange for money or drugs (1 = Yes; 0 = No)?”
Systemic Variables
The systemic domain was measured using two ordinal variables that targeted the
social and transactional elements of illegal activity that can have limited social control
mechanisms. First, participants were asked, “How often a friend traded, sold, or dealt
drugs in the 6-months prior to their arrest date (1 = Never; 2 = Sometimes; 3 = Often)?”
Second, participants were asked, “How often a friend did other things against the law in
the 6-months prior to their arrest date (1 = Never; 2 = Sometimes; 3 = Often)?”
Grouping Variable
Violence victimization were used as the grouping variable in the discriminant
function analyses. To measure violence victimization participants were asked, “If anyone
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had ever hurt them by striking or beating them to the point they had bruises, cuts, or
broken bones (1 = Yes; 0 = No)?”
Risk Behaviors for Infectious Disease
Two dichotomous variables and one continuous variable were selected to measure
participant’s risk factors for acquiring or diffusing an infectious disease. These measures
were operationalized using questions from the GAIN-Risk Behaviors Screener (RBScr).
Specifically, participants were asked about their sexual history while under the influence
of alcohol or drugs, their history of sharing needles, and by who initiated them to IDU.
To measure past 12-months condom use during intercourse with male partners,
participants were asked, “Did you use a male condom in the past 12-months prior to your
incarceration (1 = Yes; 0 = No)?” To measure initiation to IDU, participants were asked,
“Boyfriend/male lover: Who shot up with the first-time injecting (0 = No; 1 = Yes). To
measure history of syringe sharing behavior, participants were asked “How many people
did you share needles within the past year?”
Mental Health Symptomology Variables
Four dichotomous variables were selected to measure participant’s mental health
symptomology. Mental health was measured using the GAIN-Internalizing Disorders
Screener (IDScr). This screening tool is meant to identify “significant” mental health
problems, as defined by problems that last for two or more weeks, that are recurring, that
keeps the participant from meeting their responsibilities, or that makes the participant feel
like they cannot go on (Dennis, et al., 2003).
The measurements included in this section were conceptual indicators for
symptomology of the following: 1) Depression; 2) Anxiety; 3) Suicidal Ideation; and 4)

48

Psychosis. Participants were asked the following questions: 1) “In the past 12-months,
have you had significant problems with feeling trapped, lonely, sad, blue, depressed, or
hopeless about the future (1 = Yes; 0 = No)?”; 2) “In the past 12 months, have you had
significant problems with feeling very anxious, nervous, tense, scared, panicked or like
something bad was going to happen (1 = Yes; 0 = No)?” 3) “In the past 12 months, have
you thought about ending your life or committing suicide (1 = Yes; 0 = No)?”; 4) “In the
past 12 months, have you had significant problems with seeing or hearing things that no
one else could see or hear or feeling that someone else could read or control your
thoughts (1 = Yes; 0 = No)?”
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Table 1: Variables Used in Multivariate Analyses
Psychopharmacologic
Prescription Opioid
Prescription Stimulant
Prescription Sedative
Heroin
Methamphetamine
Cocaine
Economic-Compulsive
Illegal Activities for
Profit
Trade Sex for
Drugs/Money
Systemic
Friend Dealt Drugs
Friend Other Illegal
Activity
Grouping Variable
Violent Victimization
Risk Factors for
Infectious Disease
Used Male Condom
IDU Initiation
Syringe Sharing
Mental Health
Symptomology
Depression
Anxiety
Suicide Ideation
Psychosis

Measurement
Temporality
Past 3Months/Lifetime
Past 3Months/Lifetime
Past 3Months/Lifetime
Past 3Months/Lifetime
Past 3Months/Lifetime
Past 3Months/Lifetime

Measurement
Type
Continuous

Values

Past 3-Months

Continuous

Past 12-Months

Dichotomous

0 = No; 1 = Yes

Past 6-Months

Ordinal

Past 6-Months

Ordinal

1 = Never; 2 = Sometimes;
3 = Often
1 = Never; 2 = Sometimes;
3 = Often

Lifetime

Dichotomous

0 = No; 1 = Yes

Past 12-Months
Lifetime
Past 12-Months

Dichotomous
Dichotomous
Continuous

0 = No; 1 = Yes
0 = No; 1 = Yes

Past 12-Months
Past 12-Months
Past 12-Months
Past 12-Months

Dichotomous
Dichotomous
Dichotomous
Dichotomous

0 = No; 1 = Yes
0 = No; 1 = Yes
0 = No; 1 = Yes
0 = No; 1 = Yes

Continuous
Continuous
Continuous
Continuous
Continuous

Analytic Plan
Demographic characteristics were presented using descriptive and frequency
analyses. Theoretical groups were examined by conducting a series of multivariate
analyses that included discriminant function analyses and binary logistic regression
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analyses. The discriminant function analyses were performed to determine if the predictor
variables could differentiate the sample based on membership to the
psychopharmacologic model, the economic-compulsive model, or the systemic model.
This analytical step allows for an examination of the sensitivity for each discriminant
function analysis in accurately predicting the theoretical models (Poulsen & French,
2008).
In addition, a series of binary logistic regressions were conducted with the same
predictor variables. This analytical step allows for an examination of the specificity of
each discriminant function analysis, by identifying which predictors were the strongest
associates of each theoretical model (Poulson & French, 2008). The second and third
research questions were examined by conducting a series of binary logistic regression
analyses. The theoretical models (i.e., psychopharmacologic, economic compulsive, and
systemic) functioned as outcomes for the behavioral risk factors of infectious disease
contraction and mental health risk factor predictor variables. Analyses were conducted
using SAS version 9.4 and SPSS version 25.
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Chapter IV: Results
Demographics
Among the overall sample (N = 400), there were 87 participants who were
predicted to more than one group following the discriminant function analyses. To
mitigate concerns of shared variance, these participants (n = 87) were removed from
subsequent multivariate analyses; however, they were included in the demographic
characteristics. Participants were on average 32.8 years old, had an 11th grade education,
were homeless 13.5 days in the year prior to incarceration, and over the 6-months prior to
incarceration the reported income was $8,467. Most participants were White (98.1%),
had children (86.8%), and had a history of violence victimization (64.5%) (see Table 2).

Table 2: Demographic Characteristics (N=400)
Age

Mean (SD)%

Range

32.8 (8.2)

18-61

Race
% White

98.1%

Married

32.0%

Education

11th grade

All Past 6-Month Income

$8,467 ($18,558)

Children

86.8

Homelessness

13.5 days (42.3)

Violence Victimization

0-180

64.5%

Psychopharmacologic Variables
Cannabis SI Score

12.2 (11.9)

0-39

Cocaine SI Score

8.4 (11.9)

0-39

Heroin SI Score

9.2 (14.2)

0-39

Methamphetamine SI Score

15.4 (15.3)

0-39
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Table 2 (continued)
Prescription Opioid SI Score

27.8 (13.8)

0-39

Prescription Sedative SI Score

19.9 (14.8)

0-39

Prescription Stimulant SI Score

6.7 (10.8)

0-39

77.4 (83.5)

0-180

Economic-Compulsive Variables
Days of Illegal Activities for Profit
Trade Sex for Drugs/Money

77.8%

Systemic Variables
Friend Dealt Drugs
Never

14.0%

Sometimes

25.8%

Often

60.2%

Friend Other Illegal Activity
Never

11.3%

Sometimes

30.6%

Often

58.4%

Mental Health Symptomology
Depression

61.3%

Anxiety

59.8%

Suicidal Ideation

10.8%

Psychosis

22.3%

Infectious Disease Risk Factors
Number of People Shared Syringes Past 12-m

3.3 (6.45)

No Condom Use

68.0%

IDU Initiated by Male Partner

34.8%
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Research Question 1
A series of discriminant function analyses were conducted to test the extent to
which predictor variables could predict the psychopharmacologic group, the economiccompulsive group, and the systemic group relative to violence victimization. Values for
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sensitivity, specificity, positive and negative predictive power are presented in Table 3.
The data yielded three significant discriminant models. The correlations between each of
the predictor variables for the three discriminant models are displayed in Table 3. A
subsample (n = 77) of participants exhibited considerable overlap in their predicted group
membership; therefore, they were removed to mitigate sampling error from the
subsequent analyses. A breakdown of the predicted groupings is presented in Figure 2.

Psychopharmacological
Group (n = 181)
Economic-Compulsive Group
(n = 77)
Systemic Group (n = 55)

Note. Results from the discriminant function analyses

Figure 2: Drugs/Violence nexus predicted groups (N=313).
Confirming hypothesis 1, the psychopharmacologic model (n = 181) indicated a
strong discriminatory ability (Klecka, Iversen, & Klecka, 1980) and had the greatest
proportion of the total sample. Overall, the psychopharmacologic model correctly
classified 87.5% of the sample and was statistically significant (Wilk’s Lambda = .389, F
= 3.94, p < 0.001). Among the three discriminant models, the psychopharmacologic
model was indicated to have had the greatest discriminatory ability. Each of the three
predictor variables were significant contributors to the model. The largest absolute
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correlate in this model was the illicit use of prescription opioids (Canonical Correlation =
0.88).
The economic-compulsive model (n = 77) indicated a moderate discriminatory
ability (Klecka, Iversen, & Klecka, 1980). Overall, the model correctly classified 79.8%
of the sample and was statistically significant (Wilk’s Lambda = .584, F = 11.86, p <
0.001). Both of the predictor variables included in the economic-compulsive model
significantly contributed to the model. The largest absolute correlate in this model was
the number of days a participant engaged in illegal activities for profit in the 3-months
prior to incarceration (Canonical Correlation = 0.86). A strong positive correlation was
observed between illegal activity for profit and violent victimization.
The systemic model (n = 55) indicated a moderate discriminatory ability (Klecka,
Iversen, & Klecka, 1980). Overall, the model correctly classified 71.9% of the sample
and was statistically significant (Wilk’s Lambda = .492, F = 6.59, p < 0.001). Both of the
predictor variables included in the system model significantly contributed to the model.
The largest absolute statistically significant predictor in this model was demonstrated by
how often the participant’s friends traded, sold, or dealt drugs in the 6-months prior to
their arrest date (Canonical Correlation = 0.96). A full display of the correlations between
the remaining predicting variable and the discriminant function are in Table 3.
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Table 3: Results from Discriminant Function Analyses
Psychopharmacological
Group

Standardized Canonical
Coefficients

RSquare

FValue

Prescription Stimulant

0.356

0.019

7.86

Prescription Opioid

0.875

0.018

7.01

Prescription Sedative

0.711

0.013

5.01

Heroin

0.805

0.032

8.93

Methamphetamine

0.537

0.038

15.21

Cocaine

0.122

0.024

4.25

Illegal activity for profit

0.861

0.043

17.35

Sex as currency

0.733

0.031

12.42

Friend's drug dealing

0.448

0.045

16.65

Friend's other illegal activity

0.638

0.049

18.28

P>F
0.10
5
0.00
0
0.02
5
0.00
3
0.00
8
0.44
0

Economic-Compulsive
Group
0.00
1
0.00
1

Systemic Group
0.00
1
0.00
1

Research Question 2
A series of binary logistic regression was conducted to examine if mental health
symptomology was associated with the predicted groups (i.e., psychopharmacologic;
economic-compulsive; systemic). As presented in Table 4, results of the binary logistic
regression indicated that there was a significant association between mental health
symptomology and psychopharmacologic violence (χ²(5, 308)=22.33, p < .001) and
economic-compulsive violence (χ²(5, 308)=37.67, p < .001), but not for systemic
violence (χ²(5, 308)=11.76, p < .138).
The variable with the strongest association with psychopharmacological violence
(OR = 2.48; CI = 1.38-4.45, p < .002) was experiencing psychotic symptoms. In addition,
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hypothesis 2 was not confirmed as economic-compulsive violence was associated with an
equal number of mental health symptomology, including depression symptoms (OR =
1.80; CI = 1.10-3.03, p < .027) and suicidal ideation (OR = 1.45; CI = 1.27-3.01, p <
.032) (see Table 4). There were no significant individual risk factors associated with the
systemic group.
Table 4: Binary Logistic Regression Analyses Results for Mental Health Symptomology
Psychopharmacological Group
Depression
Anxiety
Suicidal Ideation
Psychosis
Economic-Compulsive Group
Depression
Anxiety
Suicidal Ideation
Psychosis
Systemic Group
Depression
Anxiety
Suicidal Ideation
Psychosis

B
0.502
-0.312
-0.353
0.908

OR
1.65
0.73
0.70
2.48

95% CI
1.19-2.77*
0.44-1.21
0.34-1.45
1.38-4.45**

0.589
-0.191
0.371
1.086

1.80
0.86
1.45
0.73

1.10-3.04*
0.50-1.36
1.27-3.01*
1.70-5.15

0.063
-0.450
0.043
0.534

1.10
0.97
1.04
1.71

0.98-2.62
0.64-1.80
0.51-2.14
0.99-2.95

Note. *p < .05; **p < .01

Research Question 3
A series of binary logistic regression were conducted to examine if behavioral
health risk factors for infectious disease were associated with a discriminant function
analysis-defined model (i.e., psychopharmacologic; economic-compulsive; systemic). As
presented in Table 5, results of the binary logistic regression indicated that there was a
significant association between behavioral health risk factors for infectious disease and
psychopharmacologic violence (χ²(3, 310)=5.73, p < .05) and economic-compulsive
violence (χ²(3, 310)=9.99, p < .007). Hypothesis 3 was not confirmed as the
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psychopharmacological model did not have the greatest number of significantly
associated infectious disease risk factors.
Two variables were significantly associated with psychopharmacologic violence.
The strongest association with psychopharmacologic violence was having a partner who
initiated IDU (OR = 9.85; CI = 5.10-30.78, p < .041). The other significant association to
the psychopharmacological group was not using a condom in the 12-months prior to
incarceration (OR = 1.62; CI = 1.39-1.98, p < .045) (Table 5).
Two variables were significantly associated with economic-compulsive violence.
The strongest association with economic-compulsive violence was the number of
individuals that participants’ shared needles with 12-months prior to incarceration (OR =
2.16; CI = 2.05-3.67, p < .001). This finding indicated that the risk of economiccompulsive violence increased by approximately twice as the number of times a
participant shared a needle increased. There were no significant associations between
infectious disease risk factors and the systemic group (Table 5).
Table 5: Binary Logistic Regression Analyses Results for Infectious Disease Risk Factors
Psychopharmacological Participants
Shared Needles
No Condom
Intro to IDU
Economic-Compulsive Participants
Shared Needles
No Condom
Intro to IDU
Systemic Participants
Shared Needles
No Condom
Intro to IDU

B
0.019
0.474
2.287

OR
1.02
1.62
9.85

95% CI
.97-1.08
1.39-1.98*
5.10-30.78*

0.445
0.409
-1.456

2.16
1.51
0.23

2.05-3.67***
1.06-2.40*
.025-2.17

-0.069
0.201
-1.715

0.93
1.78
1.17

.83-1.05
1.69-3.62
.69-1.98

Note. *p < .05; **p < .01; ***p < .001

Copyright © Grant Victor 2019

58

Chapter V: Discussion
The findings of the current study provided partial support for the study
hypotheses. To that end, the intent of this chapter is to detail the findings of the current
study, to discuss policy and treatment implications, to provide guidance for future
research, and to highlight the role of social workers in meeting the needs of justiceinvolved rural women. First, explanations of the current findings are provided and
compared to past research. Second, implications and translational recommendations are
summarized generally and from a social work perspective, taking account of both microand macro-level interventions. Third, limitations of the current study and areas for future
research are presented. Fourth, a conclusory summary of the current study is provided.
This study examined the contributing factors that influenced the drugs/violence
relationship among justice-involved women in Appalachia, and it explored the
associations between the predicted drugs/violence groups and mental health
symptomology and behavioral health risk factors. The theoretical framework proposed by
Goldstein (1985) informed the conceptualization of the drugs/violence relationship types;
specifically, psychopharmacologic violence, economic-compulsive violence and systemic
violence. Goldstein’s (1985) framework was supplemented by a feminist perspective
(Chesney-Lind & Shelden, 2013) given the homogeneity of the current study sample and
as a means toward explaining the findings and implications of this study. The statistically
significant findings in this study build upon the existing literature base that has addressed
justice-involved women (Chesney-Lind & Shelden, 2013; Fogel et al., 2014; Fogel, &
Belyea, 1999; Oser et al., 2009), and the theoretically guided characteristics (Goldstein,
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1985) of justice-involved women’s experience of the relationship between drug use and
violence.
The sociodemographic characteristics indicated that the current sample had
structural and social determinants of health that are consistent with the Appalachian
region in Kentucky (ARC, 2017). The economic inequality among justice-involved
women in the current study were comparable to the majority of justice-involved
populations (Deckard, 2017; Rabuy & Kopf, 2015). The majority of the current sample
had approximately two children and on average had attained an eleventh-grade education.
According to the ASSIST instrument (Humeniuk et al., 2008), reported drug use of the
current sample ranged from moderate to severe on each drug class. On average, NMUPO
and prescription sedatives had the most severe use profiles. The drug use reported by the
current sample is comparable with most justice-involved individuals, as evidenced by
(Mumola & Karberg, 2006). Nearly two-thirds of the current sample reported violent
victimization in the 12-months prior to their incarceration; national estimates for justiceinvolved women range between 50% to 98% (Beck, Berzofsky, Caspar, & Krebs, 2013).
Theoretical Relationship between Drug Use and Violence
This study was the first to use Goldstein’s (1985) tripartite conceptual framework
to examine how psychopharmacologic factors, economic-compulsive factors, and
systemic factors predicted the drug use and violence relationships among justice-involved
women. As noted, the majority (64.5%) of justice-involved women in this sample
reported being a victim of violence in their lifetime. According to the Bureau of Justice
Statistics (Bronson & Berzofsky, 2017), the majority of justice-involved women do not
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typically have violent charges (less than 5,000) at the at the county- and national-level.
Yet, most justice-involved women have been incarcerated on drug offenses.
Presently, there are 8,500 women in federal prison on drug charges, 24,700 in
state prisons and 27,000 in local jails (Bronson & Berzofsky, 2017). This offender profile
coupled with violent victimization histories provides some evidence for the
drugs/violence relationship among justice-served women. A series of discriminant
function analyses were conducted to determine if the drugs/violence relationship factors
could discriminate between psychopharmacologic violence, economic-compulsive
violence and systemic violence among rural justice-involved women. Overall, the
findings in the current study indicated that each of the discriminant function analyses
were statistically significant.
The current findings provided novel evidence which demonstrated that
Goldstein’s (1985) conceptual framework did have utility among a sample of rural
justice-involved women. That is, among a unique subpopulation, the current findings
indicate there is are direct relationships that demonstrated the impact of
psychopharmacological, economic-compulsive, and systemic victimization. These
findings could be helpful in providing a modified conceptual framework to explore
linkages across a variety of victimization (e.g., domestic violence, sexual assault,
stalking, or suicide) and rural venues (e.g., crisis center patients, medical care patients,
substance use treatment clients, or individuals in juvenile detention).
Building evidence that is specific to rural communities is important, as Kuhns &
Clodfelter (2009) note, most victimization studies rely on nationally representative
samples that may not gather accurate information on the victim’s drug use, or reliably
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identify issues that were specific to unique at-risk populations. Further, the predicted
groups were examined by using violence victimization as the primary discriminating
variable, which largely contrasted with much of the male- and perpetration-focused
development and subsequent testing of Goldstein’s (1985) original framework. This
study also was the first to provide evidence that unique health risk-factors were
significantly associated to participants’ specific drug-related violent victimization
experiences. In other words, the findings of the current study propose of modified
framework that can be used to guide future research examining drug use and violence
victimization in rural communities.
Psychopharmacological Violence
The psychopharmacological group had the greatest number of participants
compared to the other predicted drugs/violence groups. This suggests that the
psychopharmacological drugs/violence relationship was the most prevalent to affect the
current sample. Previous research has found similar results, where
psychopharmacological violence was the most common context of drug-related violence
(Oser et al., 2009). However, comparisons are difficult because past research has given
minimal attention to violence victimization and no study has tested this framework
exclusively on rural justice-involved women.
Yet, when comparing the current results to past research, the findings of this study
may indicate that the pervasiveness of psychopharmacologic violence spans across the
urban-to-rural divide, between men and women, and within the contexts of violence
perpetration and victimization. Perhaps an explanation for the pervasiveness of this type
of drug/violence relationship is based on the notion that the psychopharmacological
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violence is distinct from the other two drugs/violence subtypes (Goldstein, 1985). That is,
the psychopharmacologic violence designates that the risks for drug-related violent
victimization exists mainly in the effects of the drugs, rather than within certain socioeconomic contexts (i.e., economic-compulsive or systemic) (Goldstein 1985).
Compared to the other groups, the psychopharmacologic group also had the
greatest discriminatory ability which indicated it was the most reliable model in
predicting the drugs/violence relationship. In the specified discriminant function model
for psychopharmacologic violence, women who reported NMUPO, heroin use,
prescription sedative misuse, and methamphetamine use in the 12-months prior to
incarceration were significantly discriminated between those with violent victimization
histories and those who did not. NMUPO and heroin use had the strongest correlation to
violence victimization, and prescription sedative use followed closely behind. These
findings contrast with much of Goldstein’s (1985) conceptualization of
psychopharmacological violence. Most of the significant correlates of the predicted
psychopharmacological group typically produce an acute depression of cognitive and
psychomotor functioning. Much of Goldstein’s (1985) writing on psychopharmacological
violence noted the profound effect that stimulant use had on violent behavior. Given
these discrepancies, the current findings are important considerations for vulnerable rural
women and for the perspective of survivors of violence rather than perpetrators of
violence.
Framed in the context of Goldstein’s (1985) tripartite conceptual framework, the
finding relative to NMUPO and heroin use is counter to a substantial portion of literature
involving the drugs/violence nexus. Past research has been largely conceptualized as the
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perpetration of violent behavior (Boles & Miotto, 2003; Goldstein, 1985; 1998) or
commitment of violent crime (Basile, 2005; Harrison & Schehr, 2005; Oser et al., 2009).
NMUPO among the current sample suggests that Goldstein’s framework could be
adapted to the experiences of rural justice-involved women. To that end, this study
provides evidence that prescription opioids and heroin may alter an individual’s behavior
in such a manner as to bring about that individual’s violent victimization. Thus, future
applications of Goldstein’s (1985) framework with rural justice-involved women may
consider the unique implications that NMUPO and heroin use have with violence
victimization.
Although Goldstein’s (1985) conceptual framework offers a robust explanation
for the drugs/violence nexus, it may be limited in its applicability to describing
experiences of victimization and NMUPO, prescription sedative use, and heroin use. The
relationship between these drugs and violence may be explained in part by bodily pain;
although, the type or severity of pain was not identified in the current study. In addition,
if bodily pain was present, it may have been the result of past victimization. Past research
has found that NPOUs were significantly more likely than nonusers to have a history of
IPV, and more likely to experiences violent victimization from someone other than their
intimate partner. An IPV event can also produce symptoms beyond the acute stage; such
as residual symptoms, which include headaches, back pain, gynecological problems,
abdominal problems, and chronic disease (Campbell et al., 2002; Coker et al., 2002; Wu,
Huff, & Bhandari, 2010). Given these findings, and because this study could not directly
ascertain the temporal events of the drugs/violence relationships, it is possible that the
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results in the psychopharmacological group were indicative of a circular pattern of drug
use, violence, and coping with the associated pain symptomology.
However, methamphetamine use was also significantly associated with
psychopharmacological group membership. This finding was consistent with past
research, as existing literature has continued to define and replicate the association of
stimulant use and violent victimization (Boles & Miotto, 2003; Chermack et al., 2002; ElBassel et al, 2005; Goldstein, 1998; Oser et al., 2009). Therefore, the current study
confirms there was a psychopharmacologic link between stimulant (i.e.,
methamphetamine) use and drug-related violence for this sample of justice-involved rural
women.
In general, stimulant use has been found to be associated with symptoms of
psychosis such as delusions, hallucinations and paranoia (Harris & Batki, 2000), which in
turn may make an individual more vulnerable to violent victimization. Another plausible
explanation may be the complex interconnectedness between participants’ substance use,
their intimate partners’ stimulant use, and the wider dynamics of power and control place
them at a greater risk violent victimization (Gilchrist et al., 2019; Snell-Rood et al.,
2016).
Economic-Compulsive Violence
There was statistically significant support for the relationship between economiccompulsive measure and violence victimization. The results from the current study
indicated that both a history of illegal acts for profit and trading sex for drugs/money
contributed to predicting economic contexts for violence victimization. Both factors
included in the economic-compulsive model significantly discriminated between
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predicted victims of violence to those who were not predicted to be victims of violence.
On average, the participants who were predicted into the economic-compulsive group
reported less income compared to the other two groups. Although this income disparity
was not statistically significant, it may signify an economic gradient effect within a
sample of predominantly low-income individuals. This economic gradient effect could
partially explain why certain participants were predicted into the economic-compulsive
group and their motivations for behavior that placed them at risk for infectious disease
and mental health issues.
The number of days a participant engaged in illegal activity for profit was the
strongest correlate to violence victimization, which is a finding that is corroborated by
past research involving justice-involved individuals in rural Kentucky (Oser et al., 2009).
Rural residents might have extensive histories of arrest and illegal activity because of
their undertreated or untreated behavioral health concerns – including addiction – which
may in turn impact employment (Browne et al., 2016; Conger, 1997; Victor et al., 2018;
Warner & Leukefeld, 2001). To that end, in the current study sex work in exchange for
money and drugs was also a strong correlate of violent victimization.
Women who engage in sex work are often vulnerable as they are positioned at the
intersection between victimization and criminality (Shdaimah et al., 2013). Research on
this topic has showed that many women who engage in sex work suffer from numerous
chronic and acute behavioral health issues including victimization and trauma, substance
misuse, mental health disorders, physical health disorders, and structural determinates of
health (e.g., housing stability and transportation) (Chapkis, 2000; El-Bassel et al., 2001;
Nussbaum, 2017; Wiechelt & Shdaimah, 2011). Collectively, the risky economic
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situations identified in this study and others are often drug-related, and can lead to
victimization (e.g., being a victim of assault during a sexual transaction). It is
recommended that treatment and policy efforts aimed at improving drug use- and
violence-related outcomes ought to consider the interconnectedness of both issues as they
pertain to social and economic determinants of health (Dasgupta, Beletsky, & Ciccarone,
2018).
The economic-compulsive model findings may be suggestive of the previously
mentioned economic distress that has affected many rural regions and especially rural
Kentucky (ARC, 2017). The Appalachian region of Kentucky has been beleaguered by a
lack of employment opportunities and static economic growth. In comparison to U.S.
national averages, Appalachian Kentuckians are at an educational disadvantage as they
are less likely to have a high school degree (74.1% to 80.4%) or a degree in higher
education (17.1% to 24.1%). This comports with the current study sample as they on
average had slightly less than a high school degree.
Moreover, in Appalachia Kentucky household incomes are more likely to fall
below the poverty line (14.9% to 12.5%) (ARC, 2017). The current sample were found to
have similar economic hardship, and consequentially, this may have tilted them toward
economically based crimes. For justice-involved rural women, not only did their
economic hardships perhaps orient them to criminal behavior, but it was also found to
place them at a greater risk for violence victimization, as evidenced by the proportion of
the sample that were predicted in the economic-compulsive group.
Using a gender-responsive perspective, the dynamics of an abusive intimate
relationship may provide another explanation for the predicted economic-compulsive
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group. It is crucial that SUD treatment providers understand that abusive partners often
actively destabilize a victim’s personal agency and the resources that may influence
whether they utilize treatment. For instance, the abuser may use a victim’s addiction as a
means of control by isolating them from sources of support and by using the stigma of
addiction to undermine the victim’s credibility. The range of drug use as a means of
control extends to a victim’s ability to access their own or other’s economic support and
employment opportunities (Matjasko, Niolon, & Valle, 2013). This scenario would
plausibly place a victim in precarious economic standing, so higher risk (i.e., sex work
and other illegal activity for profit) and often illegal means of subsidizing their own
livelihood and ability to avoid a potentially traumatic withdrawal may be engaged
(Shdaimah, & Wiechelt, 2013).
Systemic Violence
Overall, the systemic model was significant, and it produced a strong significant
correlation – the number of times a participant’s friend sold or diverted drugs – in
predicting drug-related violence. Although past research examining rural probationers has
failed to find any significant associations between drug use and systemic violence (Oser
et al., 2009), the current findings were congruent with drug diversion within rural social
and kinship networks and the role opioids play within the socio-economic context of the
region. The availability of prescription opioids has increased in the majority of regions in
the U.S. over the past two decades, and there is evidence suggesting it has had a greater
increase in rural areas (McDonald, Carlson, & Izrael, 2012). Sales data of prescription
medication indicate that states with large rural populations (e.g., Kentucky) are among
the highest for opioid analgesic prescriptions (McDonald et al., 2012).

68

Specifically, opioid analgesics are often prescribed for pain that is a consequence
of heavy labor, such as mining. In addition, qualitative research from Appalachian
Kentucky has described opioid use undergirds the work-life functionality of the region
(Leukefeld, Walker, Havens, Leedham, & Tolbert, 2007). Given the higher density of
opioid prescribing in rural areas (McDonald et al., 2012), past research has suggested that
opioids are diverted within family and kinship networks (Green, Serrano, Licari, &
Budman, 2009; Inciardi, Surratt, Cicero, Kurtz, Martin, & Parrino, 2009), in part so that
individuals can maintain long periods of manual labor (Leukefeld et al., 2007). However,
most individuals working in the Appalachian coal industry and heavy labor jobs have
traditionally been men (ARC, 2017). It may be that economic hardship has strained not
only the predominantly male workers themselves, but also those in the broader social
network (e.g., wives, partners, sisters, daughters, etc.). This could in-turn increase the risk
for illicit drug use and diversion in an area with a high concentration of opioid
prescribing (Jonas, Young, Oser, & Leukefeld, 2012).
This systemic environment could then pose a risk, as it has been well evidenced
that geographical context shapes drug use (Galea, Ahern, & Vlahov, 2003; Nandi et al.,
2010), including factors of poverty and unemployment. Because drug markets in rural
areas are predominately organized by close kinship and social networks, the diffusion of
NMPO occurs at a greater rate than is does in urban regions (Keyes et al., 2014). Despite
the limited economic capital in Appalachia Kentucky, there is evidence that indicates the
use and diffusion of OxyContin has been significantly associated with increased social
capital in rural areas (Jonas et al., 2012).
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That is, distribution networks of NMPOs is integrating into the social fabric that
has been established not by informal transactions in urban areas, but by individuals that
often have close relationships, familial ties, or intimate relationships. These broad social
networks with close personal ties that facilitate NMPO diffusion have been described as
providing an increase in social capital in the community; ergo, an increase in status and
power. It is then plausible to postulate that women may be more vulnerable in these
transactions, especially if the distributor is an intimate partner, given the higher rates of
IPV among rural women (Peek-Asa, Wallis, Harland, Beyer, Dickey, & Saftlas, 2011).
As a result, rural systemic violence victimization may be described as a recursive pattern
of IPV and self-medication, where the medication is provided by the perpetrator or a
close acquaintance. This hypothesis is supported by the past research that found that
female probationers who were NMPOs were significantly more likely than nonusers to
have experienced IPV (Hall, Golder, Higgins, & Logan, 2016; Wu et al., 2010).
Compared to the psychopharmacological and the economic-compulsive groups,
this group had the fewest number of predicted participants (n = 55). This may be due to a
lack of conceptual development in Goldstein’s (1985) conceptual framework around rural
drug markets, and perhaps due to imprecise measurement operationalization in the
current study due to the use of secondary data. These results are not entirely surprising
given the nuanced differences between urban drug markets – in which the Goldstein’s
(1985) framework was developed – and rural drug markets. Much of Goldstein’s (1985)
systemic case for drug-related violence was predicated on territorial disputes, retribution
for a variety of reasons (e.g., death of a gang member or selling low-quality drugs), and
the elimination of confidential informants. Although there is some evidence of rural
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gangs and gang members (Evans, Fitzgerald, Weigel, & Chvilicek, 1999; Swetnam &
Pope, 2001), there is little support for widespread gang-related drug markets in rural
areas such as Appalachian Kentucky.
Taken together, the findings relative to the systemic group may provide the
greatest evidence for the incongruence between Goldstein’s (1985) conceptual
framework as it is defined, and how it is portrayed in the lives of rural women. Rural
drug-market systems do appear to function in a similar fashion to urban drug-market
systems in that the distributors possesses a fundamental power differential to the
recipient. However, the nature of these interactions potentially poses contrasts in that
urban drug-market systems are largely managed by gangs, whereas rural drug-market
systems are predominantly interwoven into kinship and social relationships in the
community. In other words, rural drug-markets may be aptly described as less centralized
than drug-markets that are dominated by gangs and gang violence. This rural drug-market
configuration then may offer a new perspective of systemic violence, one that is not
centralized by gang violence and turf wars, but by violence that occurs within the context
of known personal/intimate relationships – of which justice-involved women are
particularly vulnerable (Hall et al., 2016; Oser et al., 2009).
This may indicate that rural drug markets are not necessarily fringe sectors of the
community controlled by large organizations (e.g., gangs), but rather interwoven not only
into the community but also within familial and social networks that are both formal and
informal. And for women, this may mean navigating complex personal and intimate
relationships that transcend the traditional, and often superficial relationships within an
urban drug market; although, this study failed to determine the validity of such a claim.
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Future research should continue to explore the systemic nature of rural drug markets and
how their dyadic properties might place justice-involved women at a risk for violent
victimization.
Findings among Mental Health and Infectious Disease Factors
Mental disorders and infectious diseases are more common in justice-involved
individuals than they are among the general population (Fazel & Baillageon, 2011).
These high rates of behavioral health concerns may by connected to the nature of their
lives, which for many included violence, substance use, and high-risk sexual activity.
These issues are compounded for many justice-involved women in Appalachian jails, as
drug use is prevalent and IDU is the preferred route of administration, service availability
is limited, and there is evidence to suggest women in this region are apathetic to the
health risks associated with IDU (Staton-Tindall et al., 2015b). Outside of the substantial
health-risks associated with IDU, the social aspects of power and control that are related
to IDU place many women in a position of greater vulnerability. Compared to men who
inject drugs, women are more likely to introduced to IDU by an intimate partner, a dealer,
or another family member (Tompkins, Sheard, Wright, Jones, & Howes, 2006).
Many individuals with mental illness cycle through jails on a continual basis.
Estimates reveal that individuals with severe mental illness are admitted to jails at about
8-times the rates that they are admitted to psychiatric centers (Ditton, 1999). Evidence
indicates that jail-based women have greater prevalence of severe mental illness and
significantly greater rates for major depression (Sacks, 2004). In addition, women who
are detained in jails have high rates of co-occurring substance use and mental illness
(Sacks, 2004). In addition, several studies have indicated the relationships between drug
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use and IPV, and the intersecting factors of depression, PTSD, and intimate partners’
drug use (Rivera, Phillips, Warshaw, & Lyon, 2015). This study has attempted to move
this literature forward by investigating how behavioral health risk factors may be
associated with specific drugs/violence relationships.
Mental Health Symptomology
Among justice-involved women, several studies have evidenced high rates of
mental health problems (Sacks, 2004). Findings from the current study indicate that rates
of mental health problems are relatively high compared to other samples. Specifically,
about 61% of women in this sample reported symptoms of major depression, which is
higher than in other studies of justice-involved women (15-25%) (Teplin, Abram, &
McClelland, 1997). Rates for reported anxiety symptoms were also high among the
current sample at approximately 59%, as ther studies have reported anxiety levels at
around 18.5% (Binswanger, Merrill, Krueger, White, Booth, & Elmore, 2010). In
addition, prevalence for symptoms of psychotic illness were notably higher in the current
sample at nearly 22%, compared to 3.9% nationally (Fazel, Hayes, Bartellas. Clerici, &
Trestman, 2016). However, prevalence of suicidal ideation was lower at about 10%
compared to other jail-based estimates, which indicated prevalence at approximately 16%
(Schaefer, Esposito-Smythers, & Tangney, 2016).
The binary logistic regression analyses produced several statistically significant
associations between mental health symptomology and the psychopharmacological and
economic-compulsive violence. The findings indicated that endorsement of symptoms of
depression and of psychosis were both significantly associated with increased odds of
psychopharmacological violence and economic-compulsive violence. In addition,
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suicidal ideation was significantly associated with an increased odds of economiccompulsive violence.
The findings relevant to depression and psychotic symptomology are consistent
with past research involving justice-involved women (Staton-Tindall et al., 2015b).
Evidence also suggests that IPV, drug use, and mental health conditions are
interconnected and complex (Connelly, Hazen, Baker-Ericzen, Landsverk, & Horwitz,
2013; Golder, Connell, & Sullivan, 2012; Jaquier, Flanagan, & Sullivan, 2015; Peters,
Khondkaryan, & Sullivan, 2012). There is also evidence that indicates that depression
may have a mediating effect on the relationship between substance use and IPV. For
instance, among a nationally representative sample of women, it was discovered that
women who had experienced IPV and depressive symptoms were more likely to have
more severe substance use (La Flair, Bradshaw, Storr, Green, Alvanzo, Crum, 2012).
Another study found that women who reported moderate to severe depressive symptoms
were about 8-times more likely to report both violent victimization and substance-related
problems (Paranjape, Heron, Thompson, Bethea, Wallace, & Kaslow, 2007).
Taken together, the current findings and past research suggest that drug use,
violence victimization, and depression may have cumulative effects. Women in the
current sample were predicted in the psychopharmacological due to the likelihood that
their experience of drug-related violence was best explained by the effects of the drugs on
the consumer (Goldstein, 1985). For example, participants may have used drugs to
mitigate their mental health distress related to depression and psychosis; although, drug
use has been found to longitudinally intensify mental health issues (Sullivan & Holt,
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2008), and according to the psychopharmacological group, also increase their risk of
violent victimization (Goldstein, 1985; 2003).
The rate of psychosis symptomology (22.3%) was notably higher in the current
sample compared to many nationally (Lamb & Weinberger, 1998) and internationally
(Fazel & Seewald, 2012) prevalence rates. Not only was prevalence for psychosis
symptomology higher in the current sample, but it was the strongest mental health
association, as it increased the odds of psychopharmacological violence by 2.48 times. A
recent systematic review found that criminal victimization of persons with severe mental
illness ranged from 2.3 to 140 times higher than reported in the general population
(Maniglio, 2009; Swartz & Bhattacharya, 2017).
This prevalence may be partially explained by the limited provider resources
available to individuals with psychotic illness in Kentucky’s Appalachian region, who
may in-turn be placed in county jails (Moody, Satterwhite, & Bickel, 2017). That is, in
Appalachia Kentucky accessing treatment is difficult for many, and especially so for
those with severe mental illness concerns. Mental health treatment access in rural
Kentucky is often prohibited by travel distances with sparse public transportation
resources, costs for the uninsured, and simply fewer specialized mental health providers
(Moody et al., 2017). In addition, as demonstrated in the current study and others, women
with psychotic symptomology often have low social functioning, have difficulties
consistently securing housing and employment, and have comorbid SUD that increase the
risk of victimization (Fazel, Långström, Hjern, Grann, & Lichtenstein, 2009; Latalova,
Kamaradova, & Prasko, 2014).
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To date, this study is the first to examine the association between suicidal ideation
with Goldstein’s (1985) conceptual framework. Those in the economic-compulsive group
were significantly associated with about a 1.5 greater odds of reporting suicidal ideation.
Among jail inmates, suicidal ideation often precedes suicidal behavior and has been
strongly correlated with completed suicide (Schaefer et al., 2016). From a
sociodemographic perspective, white female jail inmates have been found to report
suicidal ideation and attempt suicide at higher rates than black and male inmates
(Charles, Abram, Mcclalland, & Teplin, 2003; Schaefer et al., 2016).
Importantly, the current results should be contextualized within the economiccompulsive group of drug-related violence. It may be that a greater dissatisfaction with
life emerges from the conditions of working in an illegal economy in which sex is
exchanged for drugs and money, and coercion and victimization is common. There is
evidence to support this claim, as female sex workers who experienced sexual coercion
and had issues related to substance use were more likely to report suicidal ideation
(Hong, Li, Fang, & Zhao, 2006; Ling, Wong, Holroyd, & Gray, 2007).

However,

much of this research has been conducted outside of the U.S. and is difficult to generalize
to a unique rural subpopulation, such as justice-involved women in Appalachia
Kentucky. There is less evidence to point to women who sell drugs for profit and an
association to suicidal ideation; therefore, perhaps this finding is better explained from
the economic conditions the drive these behaviors, and not the behaviors in-and-ofthemselves.
The distressed economic conditions that span nearly all the Appalachian
Kentucky region may be a key factor in the association between suicidal ideation and
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economic-compulsive violence. Previous studies that deployed interview and survey data
from diverse cohorts have found financial distress as a contributing factor to suicidal
ideation and behavior (Duberstein, Conwell, Conner, Eberly, & Caine, 2004; Gertner,
Rotter, & Shafer, 2019; Hempstead, & Phillips, 2015; Zhang, Conwell, Zhou, & Jiang,
2004). A recent study found that marginal (i.e., ~$1.00) increases in state’s minimum
wage policy was associated with a 1.9% decrease in annual suicide rates (Gertner et al.,
2019). Advancements in economic policy and furthering economic development for
justice-involved women may be a critical step in improving the mental health concerns
among the current sample.
Although, long-term improvements to the financial security and the Appalachian
labor markets – both of which have deteriorated over the past few generations – will be
needed to sustain suicide ideation and other mental health and drug use concerns (Case &
Deaton, 2017). Improving behavioral health treatment resources that are accessible is
critical to curbing the mental health concerns previously mentioned. Justice-involved
women with comorbid disorders are significantly more likely to have multiple problems
in terms of employment, family relations, and health. In addition, they are at greater risk
for unsuccessful treatment, recidivism, homelessness, violence victimization, and suicidal
ideation/behavior when compared to those without this combination of disorders
(Schaefer et al., 2016).
From a clinical perspective, evidence suggests that screening instruments in jail
settings is an effective method of identifying high-risk individuals, employing safety
planning, and coordinating appropriate care to mitigate the risk of escalating suicidal
ideation or behavior. However, identifying those at the greatest risk is difficult, and the
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current screening instruments and clinical contacts may not fully capture individual risk
factors (Hayes, 2010). Therefore, continued research is needed to better identify those at
risk for suicide among jail-based populations. Since suicidal ideation is strongly
associated with, and often precedes suicidal behavior, this study explored how suicidal
ideation might be associated with constructs of drug-related violence.
Those who are white, female, and who report violence victimization in
association to their role in illegal drug markets and sex work may be at the greatest risk.
Given the novel findings offered by the current study, and their potential for clinical
implications, the generalizability of these results should be placed within a specific
context. That is, the measurement of suicidal ideation in this study could not contain the
nature of the suicidal thoughts. And, measures for the frequency and intensity of suicidal
thinking were not captured. Finally, the current sample is unique to many of jail
populations in that they were predominately white and rural, and generalizing clinical
implications should only be considered in these contexts.
Risk Factors for Infectious Disease
The results of the current sample are in some ways congruent with the existing
literature base. This study found that several significant associations between risk factors
for infectious disease and each of the drugs/violence groups. As compared to the other
predicted theoretical groups, the greatest number of associations of infectious disease risk
factors was found with the psychopharmacological group. The most robust association
was having a boyfriend/male partner introduce IDU to the participant. Among the
participants who were introduced to IDU by a boyfriend/male partner, their odds of
experiencing psychopharmacological violence were approximately 9-times greater than

78

for those who were not introduced in IDU in such a manner. This finding indicates that
there may be a strong connection between social and structural violence, power relations
within intimate relationships, and how these elements shape rural justice-served women’s
risk environment.
The role of violence, specifically violence perpetrated by an intimate partner, has
been found to be a factor that might increase the risk of infectious disease (e.g., HCV)
(Bourgois, Prince, & Moss, 2004). Compared to men, women who inject drugs have been
reliably shown to be at greater risk for sharing injection equipment (e.g., syringes,
cotton), and to be more reliant on male injection partners for both drugs and injection
equipment (Frajzyngier, Neaigus, Gyarmathy, Miller, & Friedman, 2007). In addition,
numerous studies have found that women are more likely to be second to inject when
women are injecting drugs with a male partner (Bennett, Vellmann, Barter, Bradbury,
2000; Frajzyngier et al., 2007; Shaw, Shah, Jolly, & Wylie, 2007).
The current findings suggest a positive, and strong association with injection
partnerships and drug-related victimization. Furthermore, this study also found a positive
association related to condom use and psychopharmacological violence. Participants were
nearly twice more likely to forget to use a condom because of the affects of their drug
use. These finds build on current literature that has investigated injection partnerships and
sexual relationships, and on the theoretical understanding of Goldstein’s (1985)
conceptual framework. As observed in the current sample, the increased odds of
psychopharmacological violence due to injection initiation and a sexual relationship
might be explained by resource dependence and power imbalances.
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Participants who may have been dependent on their intimate partner for drugs or
injection materials and may have also experienced restricted control over their own
injecting behavior (Lazuardi et al., 2012; Morris et al., 2014). The formation of this type
of high-risk dyad might be constructed based on coercive control and violence; however,
feminist scholars (Nussbaum, 1995; Nussbaum, 1999) and researchers (Bourgois et al.,
2004; Harvey, Bird, Galavotti, Duncan, & Greenberg, 2002; Pulerwitz, Amaro, De Jong,
Gortmaker, & Rudd, 2002) have noted that inertness and the denial of autonomy can be
reinforced by traditional gender-roles. Therefore, the inertness (Nussbaum, 1995) of a
participant may be compounded by the effects of drug use and violence, leading to a
passive role in the injection process, but the origins of this passivity might be best
described by cultural gender norms.
It is important to note that this study was unable to directly evaluate if relationship
power or cultural gender norms in shaping injecting practices. Further, although the
initiation of IDU does place an individual at higher risk for infectious disease contraction
and transmission (Van Handel et al., 2016), this study was unable to determine the
sequencing of injection behavior or if contaminated syringes were used. However, the
current data did demonstrate that risk profiles differ in terms of the drugs/violence
relationship, where the psychopharmacologic group showed unique risk in terms of
injecting behavior for rural justice-involved women.
Additionally, women in the current sample may have viewed their initiation to
and continuation of IDU as a “reward” and “cost” dilemma (De et al., 2009; Hahn,
Evans, Davidson, Lum, & Page, 2010; Morris et al., 2014). In this scenario, the “reward”
is an increased closeness to her partner, extended trust within the relationship, and
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mitigating of future violent events. The potential “cost” would then entail HCV
transmission and a greater dependence on a male partner for drugs and injection
equipment. The possible “costs” mentioned have been found to be more likely discarded
within cohabitating sexual relationships (Rhodes & Quirk, 1999), which was evidenced
in the current study when considering the findings related to condom use.
The economic-compulsive group was also statistically significantly associated
with an infectious disease risk factor. That is, each additional time a participant shared
syringes, their increased risk of economic-compulsive violence nearly doubled. Victims’
of economic-compulsive violence are commonly individuals who reside in the same
community as their perpetrator, and often the victims are engaged in illegal activity
themselves (e.g., (Goldstein, 2003). Within this context, drug users and distributors as
well as sex workers are common targets of economic-compulsive violence (Goldstein,
2003).
The current findings appear to align with the contemporary understanding of how
macro- and micro-level environment factors impact economic autonomy, substance use,
syringe access, gender-power imbalances, and violence. That is, a statistically significant
factor in predicting the economic-compulsive group included sex work in exchange for
drugs and money. In general, sex work is framed within a patriarchal hierarchy, by way
of gender-power imbalances, gender-based violence, and by policy measures that favor
punitive measures that are linked to increased risk for infectious disease (Shannon et al.,
2015).
Relative to the economic-compulsive group, distressed economic conditions
undergird many women’s entry into sex work and the risk conditions associated with
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sharing syringes (Reed, Gupta, Biradavolu, Devireddy, & Blankenship, 2010). In other
words, an economic vulnerability diminished participants’ negotiating power, which
resulted in statistically significant greater risk for unprotected sex and sharing syringes –
both of which investigated in this study and both are risk factors for HCV (LelutiuWeinberger et al., 2009).
Limited negotiating leverage and the desire to mitigate drug withdrawal
symptoms may mean that participants’ most viable capital option was sex work. And, as
mentioned, the gender-based inequalities that marked these exchanges may have also
required that women were not first to inject and were subjected to use contaminated
syringes. In addition, it is important to note the economic burden of dual roles (e.g.,
financially support children or other family members) that were faced by participants
who were mothers, which was most of the sample.
These factors mediate HCV vulnerability by reducing participants access to
condoms, sterile injection equipment, and HCV prevention and treatment. Structural
intervention strategies that modify the physical risk environment, which may reduce
participants’ vulnerability to HCV infection, such as the provision of childcare at harm
reduction programs and gender-specific – perhaps women-only – drug treatment
programs (Rhodes & Treloar, 2008). Therefore, programs aimed at economic
development in Kentucky’s Appalachian region ought to consider how gender-based
economic inequalities intersect with women’s social- and health-based issues.
Among a community-based sample in Appalachian Kentucky, syringe sharing
was estimated at 10.5% for receptive sharing and 26.3% for distributive sharing (Havens,
Walker, & Leukefeld, 2007). A subsequent study reported prevalence of 16.7% for
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receptive and distributive sharing combined (Young, Jonas, Mullins, Halgin, & Havens,
2013). Another study estimated receptive syringe sharing was higher among HCVpositive participants (30.2%) compared to HCV-negative participants (15.2%) (Havens,
Lofwall, Frost, Oser, Leukefeld, & Crosby, 2013). This region continues to be at highrisk for HCV/HIV rapid outbreak (Van Handel et al., 2016), and rural justice-involved
women, such as those included in this study, may be particularly vulnerable to this
potential outbreak.
Since 2015, Kentucky legislature has progressed from considering syringe service
programs (SSP) illegal, to having approximately twenty-five operational SSPs (Bixler et
al., 2018). Although the level of implementation, accessibility, and public support are
mixed, Kentucky has considerably expanded its SSPs, where by 2017 it is estimated that
31 counties and 8,078 persons had operational SSPs (two offering mobile services)
(Bixler et al., 2018). Among the 54 Kentucky counties that were vulnerable to rapid
HIV/HCV outbreak (Van Handel et al., 2016) – many of which are in Appalachia – 39%
had SSPs in operation (Bixler et al., 2018). Nearly all (83%) of Kentucky’s SSPs offer
infectious disease (i.e., HIV; HCV; STI) screenings, and all offer linkages to treatment
services.
These are promising steps forward; however, critical services for rural justiceinvolved women are underdeveloped. For instance, family planning (58%), pregnancy
testing (63%), and prenatal services (83%) are not comprehensively offered (Bixler et al.,
2018), which may be especially critical as Kentucky and other states substantially
criminalize women’s reproductive rights. In addition, only 25% of SSPs offer housing
assistance, transportation services, food assistance, while 42% offer health insurance
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enrollment (Bixler et al., 2018). If these programs continue to evolve and are funded
appropriately, Kentucky’s lawmakers should consider the unique needs of their justiceinvolved women, as there is an opportunity for the expansion of these programs that
integrate the health, social, and economic needs of justice-involved women.
Recommendations for Substance Use Disorder Treatment Providers
It is imperative to recognize that most women do recover from abuse and prove
extraordinary resilience in the face of substantial barriers related to enduring violent
victimization. In addition,, most women who use drugs do so without developing a SUD,
and among those who do, many have not been a victim of violence. Survivors may
pursue professional aid to address substance use problems that interfere with daily life or
contribute to mental or physical health concerns. Evidence has indicated there are
trauma-specific interventions that are effective in addressing a range of trauma-related
mental health and co-occurring conditions (Dass-Brailsford & Myrick, 2010; Fowler &
Faulkner, 2011; Macy & Goodbourn, 2012). Without addressing the specific needs of
survivors who are also dealing with an abusive partner, SUD treatment may not be
accessible or effective or may even place survivors at greater risk for harm.
These interconnecting issues are best addressed through care that is coordinated
and implemented in a manner that is responsive to gender-specific perspective (Bennett
& O'Brien, 2010; Schumacher & Holt, 2012). Considering Appalachian Kentucky,
gender-responsive peer supports should ideally be familiar with the cultural norms and
the needs of women that are unique to the region. Currently, there are two genderresponsive trauma-informed SUD treatment programs that have been rigorously assessed
that offer effectiveness: Women’s Integrated Treatment (Covington, Burke, Keaton, &
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Norcott, 2008) and Seeking Safety (Najavits, 2007). Yet, studies on the effectiveness of
alterations for justice-involved women are still needed. A recent systematic review of
trauma-focused interventions for IPV survivors (Warshaw, Sullivan & Rivera, 2013)
identified only one that was developed specifically for survivors dealing with a substance
use disorder: The Relapse Prevention and Relationship Safety (Gilbert et al., 2006)
(RPRS) exhibited potential in addressing women’s substance abuse and violent
victimization (Gilbert et al., 2006).
Moreover, challenges related to treatment engagement and attendance may
present if participants are experiencing ongoing victimization. This same point could also
apply if violent victimization is occurring outside of an intimate relationship, where a
chaotic and high-risk environment would pose barriers to treatment utilization (Victor et
al., 2018). It is vital that SUD treatment providers understand that abusive partners often
actively destabilize a survivor’s efforts toward recovery, by means of isolation from
sources of support, and use a survivor’s dependence on substances as a way of coercive
control. The implications of substance use coercion may extend to an individual’s ability
to access economic support, employment, or social support. This is in addition to the
stigma that many people experience regarding substance use, as well as trauma-related
feelings that may emerge as a result of being victimized and controlled (Warshaw &
Brashler, 2009).
Treatment Issues Specific to Jails
Most jurisdictions have drug treatment courts in place to divert offenders prior to
trial or be placed in following a conviction (Marlowe, 2003). Following the sentence, jailbased treatment interventions should be explored, as they are available and there is
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evidence of promising outcomes (Lutgen, 2018). In addition, pre-trail options related to
jail diversion should be strongly considered as should linkages to reentry services should
the individual serve a period of incarceration. For vulnerable women with complex
histories of drug use and violence victimization several options should be explored by
correctional facilities. These options may include residential treatment, outpatient and
intensive outpatient treatment, medication-assisted treatment, and therapeutic
communities (TC) (Belenko, Hiller, & Hamilton, 2013). Therapeutic communities offer
peer-led recovery that can be summarized as social, emotional, and practical support from
individuals with a shared history (Andreas, Ja, & Wilson, 2010; Solomon, 2004).
In studies that investigated TCs effectiveness compared to control conditions
(e.g., case management, traditional outpatient substance use treatment, substance use
education, traditional mental health treatment) there was variation in effectiveness.
Compared to traditional treatments, there is evidence that TCs have had similar and
significantly better substance use outcomes (Greenwood, Woods, Guydish, & Bein,
2001) criminal justice involvement outcomes (Welsh, 2007), employment outcomes
(French, Sacks, De Leon, Staines, & McKendrick, 1999) and mental health outcomes
(French et al., 1999; Leon, Sacks, Staines, McKendrick, 2000).
Therapeutic communities services may offer a different option for state
correctional systems and the courts, and for those clients who fail to connect with formal
outpatient, intensive outpatient, or short-term residential treatment. Further, by being free
from treatment facility licensure, accreditation standards, and medical-model treatment
approaches, the recovery model is potentially far less costly than traditional treatment50.
Vulnerable populations in medically underserved areas, such as the current sample, may
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find TCs as an increasingly resourceful option amidst rising substance-related problems
and declining resources to deal with the problem.
Compared to prisons, jails have frequent turnover and shorter average stays
making them a significant potential intervention point for treatment. Therefore, some of
the most viable jail-based treatment options are Screening, Brief Intervention, and
Referral to Treatment (SBIRT) interventions (Chandler, Fletcher, Volkow, 2009). Many
of SBIRTs incorporate the Transtheoretical Model of Change and Motivational
Interviewing (MI). These interventions are effective because they are adaptive to the
needs of the clients, they enhance communication and engagement, and they provide a
low-demand way to explore the major experiences that require clincal focus, and because
they provide ways to navigate client’s ambivalence (Miller & Rollnick, 2009; Wahab,
2006).
Evidence from recent studies indicate that there are promising SBIRT models for
justice-involved women. For instance, the Jail In-Reach Intervention uses evidence-based
screening instruments to identify individuals with severe SUD (Begun, Rose, LeBel,
2011). Begun and colleagues (2011) recently tested the effectiveness of the Jail In-Reach
Intervention using a randomized controlled trial (RTC) research design with a sample of
incarcerated women. The intervention group included MI with feedback on participant’s
drug use, and a timeline follow-back interview. The control group received the standard
jail protocol, which included a resource folder with information on the available
community-based treatment. At the 12-month follow-up, the intervention group reported
significantly lower drug and alcohol use; yet, regardless of study condition, participants
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who used the community folder were three times more likely to utilize community-based
treatment (Begun et al., 2011).
The aforementioned study is one of many that has indicated that linking jail
inmates to treatment at community reentry is vital to improving post-release outcomes
(Oser et al., 2009; Peyton, 2001; Staton-Tindall et al., 2011a; Staton-Tindall, Duvall,
McNees, Walker, & Leukefeld, 2011). Providing a continuum of care for justice-involved
individuals is a key element to reducing substance use and engaging in substance use
treatment. In addition, given the linkages found in the study between drug use and
violence victimization, reductions in substance use could aid in also reducing outcomes
related to violence.
Considering economic-compulsive and systemic violence, drug treatment
interventions may also reduce the threat of victimization by improving employability,
stabilizing familial and social supports, and mitigating the involvement in high-risk
situations (e.g., sex work). In turn, many of these improved outcomes have also been
found to reducing recidivism, by addressing the root causes that significantly propel the
cyclical nature of arrest and incarceration (Staton-Tindall et al., 2011a).
Many interventions have shown effective outcomes and have been increasingly
accepted by correctional- and policy-based decision-makers. Among the most effective
interventions for jail-based drug treatment – especially the treatment of opioids – is
medication-assisted therapy (MAT). This is an evidence-based practice for jail-based
drug treatment with highly efficacious and effective outcomes (Amato, Davoli, Perucci,
Ferri, Faggiano, & Mattick, 2005; Egli, Pina, Skovbo-Christensen, & Aebi, 2009;
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Westerberg, McCrady, Owens, & Guerin, 2016; Lee et al., 2012) and with costs
comparable with traditional treatments (Horn, Mamun, McCrady, French, 2018).
For instance, a clinical trial data show MAT that is initiated during jail
incarceration can improve community-based MAT utilization and outcomes for opioiddependent individuals (Magura, Lee, Hershberger, Joseph, Marsch, Shropshire, &
Rosenblum, 2009). Magura and colleagues (2009) randomly assigned opioid-dependent
individuals to either buprenorphine or methadone. The buprenorphine group was
significantly to continue MAT in the community upon reentry, but at the 3-month followup both groups were similar in terms of their self-reported criminal-involvement and
substance use. In the same study, the methadone group appeared to be dose-responsive,
as those who had higher doses in jail had significant increases in seeking treatment at
reentry (Magura et al., 2009).
Another study using justice-involved Appalachian women has examined how
both the licit and illicit patterns of buprenorphine use post-release from jail, and how this
use correlated with contacts with health services and recidivism (Surratt, Staton,
Leukefeld, Oser, & Webster, 2018). This study found that only 5.2% of the sample had
received buprenorphine uptake through medical channels and 23.0% reported diverted
buprenorphine use (Surratt et a., 2018). There were no reported re-arrests among those
who reported licit buprenorphine use. However, drug use frequency and severity,
including illicit buprenorphine use, were independently associated with re-arrest at the 3month follow-up period. In addition, the strongest indicator of avoiding re-arrest was
having a regular source of health care.
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The authors note that a continuum of care from a health care professional(s)
provides a therapeutic benefit for behavioral health issues, pain, and other physical health
concerns for justice-involved Appalachian women (Surratt et al., 2018). It is difficult to
neglect the promising evidence for MAT services for an underserved population in
Appalachia, in accordance with consistent health care available, but it is not entirely clear
whether health care access improves access to MAT. Nonetheless, these findings point to
the underdevelopment of MAT interventions in rural areas, whilst also providing
evidence of MAT’s effectiveness in curbing re-arrest and substance use for a unique
population group. Although the relationship between MAT and violence was not directly
examined in the current study, it may be plausible to reason that greater MAT access
through formal channels could mitigate threats of drug-related violence for the current
sample.
Increasing access to rural justice-involved Appalachian women may require a
greater integration of MAT into a suite of health care settings, including rural health
centers, primary care, and federally qualified health centers (Surratt et al., 2018). This
expansion of MAT may prove difficult, as many correctional staff and policymakers
harbor negative views of this treatment on the grounds that users are substituting one
addiction for another (Friedmann et al., 2012; McMillan & Lapham, 2005).
Nearly 83% of jails provide some type of MAT, yet much of the time access is
limited to specialized needs such as detoxification for pregnant women or for those
already on methadone maintenance at the time of arrest. Compared to jail settings, drug
courts (37.5%) and probation and parole agencies (17.0%) lag further behind in their
MAT implementation (Friedmann et al., 2012). Moreover, nearly half of all drug courts

90

of policies that forbid the use of this evidence-based practice (Matusow et al., 2013). The
resistance to MAT stems from several concerns; including, local regulations, inadequate
funding, diversion concerns, and institutional philosophy that is grounded on abstinencebased treatment (Matusow et al., 2013).
The delivery of effective drug treatment to justice-involved Appalachian women
can be considerably more challenging than in typical community settings. Efforts in
research have established consensus and a set of principles for providing effective
treatment for justice-involved persons (Chandler et al, 2009). These principles integrate
the unique characteristics of the justice-involved populations that can critically
complicate effective treatment. These include high rates of psychological conditions,
cognitive deficits, risk-taking, and criminal thinking patterns and moral competencies.
For justice-involved Appalachian women, the risk–needs–responsivity (RNR)
principle has been shown to be more effective and it may provide a useful therapeutic
tool (Smith, Gendreau, & Swartz, 2009). Included in the RNR framework, evidencebased principles for effective treatment should incorporate 1) comprehensive actuarial
assessment of static and dynamic risk factors with periodic reassessment; 2) prioritizing
treatment resources for higher-risk offenders; 3) targeting interventions for criminogenic
needs, such as criminal thinking and errors in judgment; and 4) provide treatment that is
responsive to Appalachian women’s temperament, learning style, motivation, culture, and
gender-specific needs (Taxman & Belenko, 2011).
In addition to the principles outlined above, NIDA has developed a set of
treatment principles as they apply to criminal justice populations. This set of principles
ostensibly amounts to a reflection of what addiction science experts point to as evidence-
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based practices and principles (NIDA, 2006). In concert with the principles noted above,
NIDA recommends that treatment for justice-involved populations should include: 1) be
of sufficient length, especially for those with co-occurring mental health disorders and
other social and health problems, such as the current sample; 2) increase motivation and
build skills for resisting drug use and criminal behavior; 3) include on-going monitoring
through urine testing, and use of structured rewards and sanctions to manage behavior; 4)
involve collaboration and communication between treatment clinicians and CJS staff to
monitor client progress; 5) provide continuity of care as offenders move through the CJS
and back to the community; 6) integrate treatment for offenders with co-occurring mental
health disorders; and 7) use MAT where clinically appropriate, with careful attention to
monitoring adherence.
The continued expansion and implementation of these guidelines should continue
in rural Appalachia given the documented needs of an underserved and vulnerable
population with complex needs. Although many of the treatment guidelines have
evidenced effectiveness in curbing substance use and criminal behaviors, they do not
directly address the risk for drug-related violence. Engagement in effective and culturally
competent treatment may in theory reduce the risk of drug-related violence, but there
must also be consideration as to how past and current victimization may interfere with the
treatment process. Therefore, it is important to highlight the importance of screening for
psychological distress, trauma symptoms and drug-related violence among justiceinvolved Appalachian women.
A recent systematic review recognized five evidence-supported screening tools
for psychological distress among justice-involved individuals (Martin, Colman, Simpson,
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& McKenzie, 2013). Screening, for psychological distress among women involved in the
criminal justice system may improve the overall health of women, make for a more
successful return to the community, and reduce recidivism. Additionally, given the
evidence that SUD is greater among justice-involved women compared to men (Fazel &
Hayes, 2017), and the unique risks for drug-related victimization and health risk-factors,
it is critical that rural criminal justice systems incorporate gender-specialized screened,
and addiction and general health services.
Recommendations for Research
With the current study included, the existing body of research in this area has
predominately focused on establishing statistical relationships between drug use and
violence, and the direction(s) of this phenomena. Although recently there has been more
research conducted on rural populations, much of this literature has focused on
individuals in urban settings. Due to this geographical and cultural imbalance in study,
there are still problems with the operationalization and measurement of terms, which can
adversely affect the implications of the research. The following section will provide
recommendations aimed at ways in which future research might be more valid,
comprehensive, and reflective of the issues relevant to rural justice-involved women.
Future studies should aim to improve measurement of violence victimization, and
make distinctions between IPV, that with which occurs within familial or intimate
relationships, and community-based violence. The use of and further development of
standardized measures for IPV is encouraged, as there are several instruments that have
been found effective when used separately or in conjunction (Adams, Sullivan, Bybee, &
Greeson, 2008; Beeble, Bybee, & Sullivan, 2007; Coker, Pope, Smith, Sanderson, &
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Hussey, 2001). These instruments have been found to accurately measure the nonphysical aspects of IPV, such as coercion related to mental health and substance use.
Having said that, there is still a great need to continue researching the
phenomenology of rural drug-related violence for justice-involved women, as it related to
measurement, typology, culture, and causal inferences. Although the current study has
identified several novel findings related to drug-related violence, it is still unclear how
these findings demarcate community-based victimization to IPV, and the applications of
these findings to Goldstein’s (1985) conceptual framework are still underdeveloped. That
is, the Goldstein (1985) is a useful research tool for conceptualization purposes, but its
application and operationalizability may be limited by its scope (e.g., no control for
traumatic childhood experiences), and its development concerning cultural (e.g., rural
populations) and gender (e.g., perspective of victimization) idiosyncrasies.
In addition, future research is needed to enhance the understanding of
organizational and implementation science related to evidence-based treatment for rural
justice-involved women (Taxman & Belenko, 2012). Implementation science is an
emerging field that seeks to understand pertinent factors that facilitate successful and
sustained application of evidence-based practice in various settings. Future research
should aim to guide this line of research as rural jails and rural justice-involved women
are concerned.
Future research should also consider investigating the numerous linkage points
along the sequential intercept map (Willison, McCoy, Vasquez-Noriega, Regional, 2018)
and how to best integrate intervention for rural women along this continuum. Reducing
gaps in treatment access is particularly important given the disjointed nature of the
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criminal justice system and the numerous treatment needs of rural justice-involved
women; including, limited and disparate service availability, and the issues of rurality
(e.g., long travel distances and poor public transit). A further breakdown of the needs for
future research are displayed in Figure 3.
Topic Areas

Specific Inquiries
Outcomes of jail-based treatment
Effectiveness comparisons between brief, short-term,
and long-term interventions

Jail-Based Treatment Research

Predictors of treatment outcomes
Implementation of aftercare

Structural & Social
Determinants of Jail-Based
Services

Accessibility of MAT
Barriers to treatment (e.g., cost, stigma, power &
control)
Trust and community involvement
Drug use coercion and access to law enforcement
Primary data collection with the purpose of
investigating drugs/violence nexus

Measurement

Improve data coordination between health and
criminal justice professionals
Temporal ordering of drug use and violent
victimization
Increase attention to drug-related violence as it
related to infectious diseases

Violence Victimization

The role of antecedents such as trauma and structural
violence on women’s use of drugs and criminality
Emphasis on intimate injection partnerships, highrisk injecting & victimization
Effects of dual roles (e.g., mother, wife, partner,
caretaker) on parenting, drug use and criminal
behavior

Population Factors

Impacts of poverty and marginalization on drug use
and criminality
Women’s role within rural illicit drug markets

Figure 3: Recommendations for research with rural justice-involved women.
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Role of Social Workers
Social workers are well positioned to fulfill a robust role as interventionists and
policy-makers on behalf of the vulnerable population group of justice-involved women.
The results of the current study are reflective of one of the profession’s current Grand
Challenges: The Smart Decarceration Initiative (SDI) (Herbert-Williams, 2016). To date,
many of the SDI recommendations have been developed around policy- and macro-level
innovations (Epperson & Pettus-Davis, 2016). These recommendations aimed to build
social capacity and reduce incarceration rates for vulnerable populations. Specifically,
Epperson and Pettus-Davis (2016) four recommendations for the SDI were as follows: 1)
use incarceration primarily for incapacitation of the most dangerous; 2) make reduction
of disparities a key outcome in decarceration efforts; 3) remove civil and legal
exclusions; and 4) reallocate resources to community-based supports. Regarding rural
justice-involved women, social workers that are framing policy and community-based
interventions should target reductions in outcomes related to economic and behavioralhealth disparities (including violent victimization).
Social workers can also facilitate evidence-based practices for individual-level
interventions for justice-involved women. As licensed practitioners, social workers are
vital to the treatment of SUD approaches; such as, reentry services, outpatient, intensive
outpatient, inpatient, residential, and jail-based brief interventions (Kouyoumdjian et al.,
2015; Riekmann, Kovas, Cassidy, & McCarty, 2011). Social work also has a long history
in issues related to child welfare services. Most children with incarcerated mothers have
elevated levels of behavioral health issues and greater disruption given the experience of
multiple placements (Seymour, 2017).
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Social workers must continue to meet the clinical and social needs of these
children and their mothers, provide care that encourages reunification, and advocate
against the termination of parental rights due to issues related to SUD. The issues that are
relevant to child welfare concerns and justice-involved women stem from a mother’s
removal from society. To that end, diverting offenders from incarceration and toward
community services could also alleviate Kentucky’s overburdened child welfare and
criminal justice systems.
In Kentucky, an effective and cost-effective tool for diverting individuals from the
criminal justice system to treatment systems is the Alternative Sentencing Worker
Program (ASWP). Following arrest, a defendant might receive a screening, brief
intervention and referral to treatment (Babor, McRee, Kassebaum, Grimaldi, Ahmed, &
Bray, 2007), or be diverted to community treatment under pretrial supervision conditions
(Belenko, 1999) as an alternative sentencing (Farabee & Leukefeld, 2001). Unlike many
uniform referral services that are provided to justice-involved populations, the ASWP
works directly with clients to develop a plan that meets the client’s needs and introduces
this report for the Court’s approval.
Alternative Sentencing workers also work closely with Kentucky communities to
forge working relationships to enhance cooperation with Court officials, and to best
allocate the appropriate resources to clients. As of 2016, all eight of Kentucky’s
Alternative Sentencing workers held master’s degrees in social work. In addition, the
ASWP integrates Motivational Interviewing techniques to facilitate client’s change
processes and their participation in the program. Motivational Interviewing is an
evidence-based practice that has strong evidence of support for the services offered by
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the ASWP and within criminal justice settings more generally (Carroll et al., 2006; Miller
& Rollnick, 2002; Vader, Walters, Prabhu, Houck, & Field, 2010).
Limitations
Several limitations must be mentioned. This was a cross-sectional study that
examined correlational effects; therefore, it was unable to determine causation. This
study utilized an analysis of extant data, so the use of proxy measures was used as a
necessity, and the definition of variables was not as precise as it may have been with a
primary data source. Due to this limitation, unexplained variance may exist that was not
captured by the selected variables. Future research should incorporate multiple data
sources (e.g., correctional intake date; public health data; police records) to operationalize
variables specific to the drugs/violence nexus and to establish temporal ordering. In
addition, although efforts were located measurements that encompassed similar
timeframes, temporal ordering of drugs/violence events remained unknown.
For instance, it is unclear if acute drug use directly preceded violent victimization,
nor was it clear how traumatic antecedents in childhood and adolescents may have
contributed to substance use later in life, and thus, to victimization in adulthood.
Additionally, this study makes many conceptual references to gender as a term that
identifies the relative needs of individuals who are biologically female. It is unclear
whether any of the women in this study identify as a gender outside of the one they were
designated at birth, and in many cases the use of gender could be more accurately
described as sex. The use of gender in this context was applied so it would be consistent
with the references made to the works in the humanities and to evidence-based treatments
that identify as “gender-responsive.” Although this study was the first to examine the
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drugs/violence nexus exclusively among rural justice-involved women, the current
findings limited potential generalizations beyond the current sample or drug-involved
rural justice-involved women.
Conclusions
Among rural justice-involved women, drugs and violent victimization were
shown to be significantly connected in three possible ways (i.e.,
psychopharmacologically, economic-compulsively, and systemically). The discriminant
function analyses indicated that these relationships had varied prevalence, as the
psychopharmacological group was the most supported, followed by economiccompulsive group, and the systemic group, respectively. These different forms of drugrelated violent victimization were shown to be substantiated by numerous classes of
drugs, different structural and economic contexts, and different social contexts.
Given these findings, the phenomena of drug-related violence victimization
among rural women was mixed in its congruence with the original formulation of the
drugs/violence nexus (Goldstein 1985; 2003). For instance, the psychopharmacological
was highly prevalent and the use of methamphetamine contributed significantly to
experience of violent victimization. Yet, most drug classes that predicted membership in
the psychopharmacological group were sedative in nature, which contrasts to Goldstein’s
(1985) conceptualization that is heavily influenced by stimulant use. Further, economiccompulsive factors, such as selling drugs and sex work in exchange for drugs and money,
also significantly contributed to predicting membership in the economic-compulsive
group. This study also found support for a conceptual basis of the systemic group,
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although this group had the least number of predicated participants included in the model,
and there was no statistical support for the systemic group in subsequent analyses.
To the latter finding, this study also contributed noteworthy considerations for
how the Goldstein (1985) conceptual framework may be adapted by a greater focus on
victimization and the gender-specific experiences of rural women. For example,
Goldstein (2003) noted that per his research in New York City, is that the area of
systemic violence dominates much of the violence directed at drug users. This assertion is
not supported from the perspective of the current study. The data suggests that the
systemic group was the least influential among drug-using rural women.
The systemic group the least prevalent per the discriminant function analyses it
did not have any significant associations to the mental health factors nor the risk factors
for infectious disease. Future research involving rural justice-involved women must
evaluate drug-related violence on a spectrum based on how coercive control specifically
relates to psychopharmacological and economic-compulsive violence, and to continue to
explore ways to operationalize systemic violence in rural areas where gang involvement
is limited, if not non-existent in certain areas.
Following the construction of the three drugs/violence groups, this study was able
to identify several significant mental health concerns and infectious disease risk factors
that were associated with the psychopharmacological and economic-compulsive groups.
The initiation of injection behavior was strongly associated with psychopharmacological
violence. Risky sexual behavior and symptomology consistent with depression and
psychosis were also significantly associated with psychopharmacological violence. More
research is needed to better understand how these factors may be interrelated. Depression
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and suicidal ideation were significantly associated with economic-compulsive violence
which may highlight the complex intersection between economic distress, drug use,
structural and interpersonal trauma, and power and control. The original Goldstein (1985)
conceptual framework and subsequent reviews (Goldstein, 2003) are relatively silent on
how these conceptual factors may map onto behavioral health concerns.
To that end, this study has presented novel data that future studies can build upon
in better understanding how specific drug-related violence situations might have unique
behavioral health risks. Although this study is not conclusive, this research might be
useful in developing screening and assessment instruments in crisis centers and
correctional settings. For instance, there is now evidence that rural women who present
with economic-compulsive violence histories may be more likely to report suicidal
ideation, and that psychopharmacological violence histories may be indicative coercive
injection behavior. Social workers and other practitioners, along with policymakers, must
continue to develop coordinated and integrated interventions that are gender-responsive,
trauma informed, culturally attuned to the needs of justice-involved rural women. Lastly,
practitioners and researchers must deliberate factors outside the individual-level that will
improve policy and practice and ultimately promote the decriminalization of drug use and
the diversion of vulnerable women from jails to treatment centers and outpatient care.
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